<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Antidepressant,Antidepressants,Major Drug Groups,Antidepressants,Major Drug Groups,2006,5-HTP,ACE inhibitor,ATC code N06,Acupuncture,Addiction" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Antidepressant - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Antidepressant</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="../../../p/r/o/Image%7EProzac.jpg_96cc.html" class="internal" title="A recent form of antidepressant medication - Prozac"><img src="../../../upload/shared/thumb/2/2d/Prozac.jpg/250px-Prozac.jpg" alt="A recent form of antidepressant medication - Prozac" width="250" height="195" longdesc="../../../p/r/o/Image%7EProzac.jpg_96cc.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../p/r/o/Image%7EProzac.jpg_96cc.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A recent form of antidepressant medication - Prozac</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="../../../v/e/n/Image%7EVenlafaxine-3D-vdW.png_df7c.html" class="internal" title="Serotonin-norepinephrine reuptake inhibitor, Venlafaxine"><img src="../../../upload/shared/thumb/b/bf/Venlafaxine-3D-vdW.png/250px-Venlafaxine-3D-vdW.png" alt="Serotonin-norepinephrine reuptake inhibitor, Venlafaxine" width="250" height="275" longdesc="../../../v/e/n/Image%7EVenlafaxine-3D-vdW.png_df7c.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../v/e/n/Image%7EVenlafaxine-3D-vdW.png_df7c.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Serotonin-norepinephrine reuptake inhibitor, Venlafaxine</div>
</div>
</div>
<p>An <b>antidepressant</b>, in the most common usage, is a <a href="../../../m/e/d/Medication.html" title="Medication">medication</a> taken to alleviate <a href="../../../c/l/i/Clinical_depression.html" title="Clinical depression">clinical depression</a> or <a href="../../../d/y/s/Dysthymia.html" title="Dysthymia">dysthymia</a> ('milder' depression). Several groups of drugs are particularly associated with the term, notably <a href="../../../m/a/o/MAOI_edbc.html" title="MAOI">MAOIs</a> and <a href="../../../t/r/i/Tricyclics.html" title="Tricyclics">tricyclics</a> (whose <a href="../../../s/e/r/Serendipitous.html" title="Serendipitous">serendipitous</a> discovery and <a href="../../../p/s/y/Psychiatry.html" title="Psychiatry">psychiatric</a> use dates from the 1950s) as well as <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRIs</a> and more recent variations developed by <a href="../../../p/h/a/Pharmaceutical_companies.html" title="Pharmaceutical companies">pharmaceutical companies</a>. These medications are now amongst the most commonly <a href="../../../p/r/e/Prescription_drug.html" title="Prescription drug">prescribed</a> by psychiatrists and <a href="../../../g/e/n/General_practitioners.html" title="General practitioners">general practitioners</a>, and their <a href="../../../e/f/f/Effectiveness.html" title="Effectiveness">effectiveness</a> and <a href="../../../a/d/v/Adverse_effects.html" title="Adverse effects">adverse effects</a> are the subject of many studies and competing claims. A number of other antidepressant <a href="../../../d/r/u/Drugs.html" title="Drugs">drugs</a>, notably <a href="../../../s/t/_/St_John%27s_Wort_98c1.html" title="St John's Wort">St John's Wort</a>, are also widely studied and used.</p>
<p>Antidepressants are generally, if not in <a href="../../../p/h/a/Pharmacology.html" title="Pharmacology">pharmacology</a>, considered separately from <a href="../../../s/t/i/Stimulants.html" title="Stimulants">stimulants</a>. They are usually taken as a course over several weeks, months or years, and have a delayed onset of therapeutic action. Drugs used for an immediate <a href="../../../h/a/p/Happiness.html" title="Happiness">euphoric</a> effect only are not generally considered antidepressants. Despite the name, antidepressants are often used in the treatment of other conditions, including <a href="../../../a/n/x/Anxiety_disorders.html" title="Anxiety disorders">anxiety disorders</a>, <a href="../../../b/i/p/Bipolar_disorder.html" title="Bipolar disorder">bipolar disorder</a>, <a href="../../../e/a/t/Eating_disorders.html" title="Eating disorders">eating disorders</a> and <a href="../../../c/h/r/Chronic_pain.html" title="Chronic pain">chronic pain</a>. Some have also become known as <a href="../../../l/i/f/Lifestyle_drug.html" title="Lifestyle drug">lifestyle drugs</a>, sometimes referred to as "mood brighteners". Conversely other medications not known as antidepressants, including <a href="../../../a/n/t/Antipsychotics.html" title="Antipsychotics">antipsychotics</a> in low doses<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup> and <a href="../../../b/e/n/Benzodiazepines.html" title="Benzodiazepines">benzodiazepines</a><sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup> are also widely used to manage depression. In fact the antidepressant term is sometimes applied to any therapy (e.g. <a href="../../../p/s/y/Psychotherapy.html" title="Psychotherapy">psychotherapy</a>, <a href="../../../e/l/e/Electro-convulsive_therapy.html" title="Electro-convulsive therapy">electro-convulsive therapy</a>, <a href="../../../a/c/u/Acupuncture.html" title="Acupuncture">acupuncture</a>) or process (e.g. sleep disruption, increased light levels, regular exercise) found to improve clinically depressed mood. It is also the case that <a href="../../../p/l/a/Placebos.html" title="Placebos">placebos</a> tend to have a significant antidepressant effect, so that establishing something as an antidepressant in a <a href="../../../c/l/i/Clinical_trial.html" title="Clinical trial">clinical trial</a> involves demonstrating a significant additional effect.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Classes_and_members"><span class="tocnumber">2</span> <span class="toctext">Classes and members</span></a></li>
<li class="toclevel-1"><a href="#Prescription_trends"><span class="tocnumber">3</span> <span class="toctext">Prescription trends</span></a>
<ul>
<li class="toclevel-2"><a href="#Most_commonly_prescribed_antidepressants"><span class="tocnumber">3.1</span> <span class="toctext">Most commonly prescribed antidepressants</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Mechanisms_of_action"><span class="tocnumber">4</span> <span class="toctext">Mechanisms of action</span></a>
<ul>
<li class="toclevel-2"><a href="#Anti-inflammatory_and_Immunomodulation"><span class="tocnumber">4.1</span> <span class="toctext">Anti-inflammatory and Immunomodulation</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Therapeutic_efficacy"><span class="tocnumber">5</span> <span class="toctext">Therapeutic efficacy</span></a>
<ul>
<li class="toclevel-2"><a href="#Review_studies"><span class="tocnumber">5.1</span> <span class="toctext">Review studies</span></a></li>
<li class="toclevel-2"><a href="#Clinical_guidelines"><span class="tocnumber">5.2</span> <span class="toctext">Clinical guidelines</span></a></li>
<li class="toclevel-2"><a href="#Efficacy_limitations_and_strategies"><span class="tocnumber">5.3</span> <span class="toctext">Efficacy limitations and strategies</span></a>
<ul>
<li class="toclevel-3"><a href="#.22Trial_and_error.22_switching"><span class="tocnumber">5.3.1</span> <span class="toctext">"Trial and error" switching</span></a></li>
<li class="toclevel-3"><a href="#Augmentation_and_Combination"><span class="tocnumber">5.3.2</span> <span class="toctext">Augmentation and Combination</span></a></li>
<li class="toclevel-3"><a href="#Long-term_use"><span class="tocnumber">5.3.3</span> <span class="toctext">Long-term use</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1"><a href="#Tolerance_and_dependence"><span class="tocnumber">6</span> <span class="toctext">Tolerance and dependence</span></a></li>
<li class="toclevel-1"><a href="#Side_effects"><span class="tocnumber">7</span> <span class="toctext">Side effects</span></a>
<ul>
<li class="toclevel-2"><a href="#General"><span class="tocnumber">7.1</span> <span class="toctext">General</span></a></li>
<li class="toclevel-2"><a href="#Sexual"><span class="tocnumber">7.2</span> <span class="toctext">Sexual</span></a></li>
<li class="toclevel-2"><a href="#Thymoanesthesia"><span class="tocnumber">7.3</span> <span class="toctext">Thymoanesthesia</span></a></li>
<li class="toclevel-2"><a href="#REM_Sleep"><span class="tocnumber">7.4</span> <span class="toctext">REM Sleep</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Controversy"><span class="tocnumber">8</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1"><a href="#Lawsuits"><span class="tocnumber">9</span> <span class="toctext">Lawsuits</span></a></li>
<li class="toclevel-1"><a href="#Non-mainstream_treatments"><span class="tocnumber">10</span> <span class="toctext">Non-mainstream treatments</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Additional_reading"><span class="tocnumber">12</span> <span class="toctext">Additional reading</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">13</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="../../../s/a/i/Image%7ESaint_johns_wart_flowers.jpg_2819.html" class="internal" title="A natural antidepressant - Saint Johns Wort"><img src="../../../upload/shared/thumb/c/c4/Saint_johns_wart_flowers.jpg/250px-Saint_johns_wart_flowers.jpg" alt="A natural antidepressant - Saint Johns Wort" width="250" height="167" longdesc="../../../s/a/i/Image%7ESaint_johns_wart_flowers.jpg_2819.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../s/a/i/Image%7ESaint_johns_wart_flowers.jpg_2819.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A natural antidepressant - Saint Johns Wort</div>
</div>
</div>
<p><a href="../../../o/p/i/Opium.html" title="Opium">Opium</a><sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup> and <a href="../../../s/t/_/St_John%27s_Wort_98c1.html" title="St John's Wort">St John's Wort</a><sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup> (as a "nerve tonic") had long been used to alleviate depression (amongst many other things), but <a href="../../../i/p/r/Iproniazid.html" title="Iproniazid">iproniazid</a> was the first synthetic chemical compound generally accepted as an antidepressant. The chemical from which it was derived, <a href="../../../i/s/o/Isoniazid.html" title="Isoniazid">isoniazid</a> was independently recognized as having clinically significant effects on depression, in 1952 by Jean-Francois Buisson in France and Max Lurie in the United States, after it had come into widespread use as a treatment for <a href="../../../t/u/b/Tuberculosis.html" title="Tuberculosis">tuberculosis</a>. <a href="../../../i/p/r/Iproniazid.html" title="Iproniazid">Iproniazid</a> was then observed to have a greater "psychostimulant" effect and to inhibit the enzyme Monoamine Oxidase. Nathan Kline and colleagues conducted the first clinical trial to demonstrate a significant effect of iproniazid on depression in psychiatric patients. Kline approached <a href="../../../r/o/c/Roche.html" title="Roche">Roche</a> with what he called a "psychic energizer"<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[5]</a></sup> and the first <b>M</b>ono<b>A</b>mine <b>O</b>xidase <b>I</b>nhibitor (MAOI) was introduced as Marsilid. Sales grew massively in the following years, and others of the class were introduced by several drug companies, but adverse effects such as <a href="../../../h/y/p/Hypertension.html" title="Hypertension">hypertension</a> crisis related to food amines, and acute hepatic necrosis, curtailed their use</p>
<p>The discovery that a tricyclic ("three ringed") compound had a significant antidepressant effect was also first made in the early 1950s, by Roland Kuhn in a Swiss psychiatric hospital. By that time <a href="../../../a/n/t/Antihistamine.html" title="Antihistamine">antihistamine</a> derivatives were coming in to use to treat surgical shock and then as psychiatric neuroleptics. Although, in 1955, <a href="../../../r/e/s/Reserpine.html" title="Reserpine">reserpine</a> was indicated to be more effective than placebo in alleviating anxious depression, neuroleptics (literally "to seize the neuron") were developing for use as sedatives and antipsychotics. In attempting to improve the effectiveness of one of them, <a href="../../../c/h/l/Chlorpromazine.html" title="Chlorpromazine">chlorpromazine</a>, in conjunction with the <a href="../../../g/e/i/Geigy.html" title="Geigy">Geigy</a> <a href="../../../p/h/a/Pharmaceutical_company.html" title="Pharmaceutical company">pharmaceutical company</a>, Kuhn discovered that compound "G 22355" (manufactured and patented in the US in 1951 by Häfliger and Schinder) had a beneficial effect in patients with depression with mental and motor retardation<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[6]</a></sup> He first reported his findings on what he called a "thymoleptic" (literally "taking hold of the emotions", by contrast with neuroleptics, "taking hold of the nerves") in 1955/56 and they gradually became established, resulting in the marketing of the first tricyclic antidepressant, <a href="../../../i/m/i/Imipramine.html" title="Imipramine">imipramine</a>, soon followed by variants.</p>
<p>These new drug therapies became prescription-only medications (POM) in the 1950s. It was estimated that no more than 50 to 100 people per million suffered from the kind of depression that these new drugs would treat and pharmaceutical companies were not enthusiastic. Sales through the 1960s remained poor compared to the <a href="../../../m/a/j/Major_tranquilizers.html" title="Major tranquilizers">major tranquilizers</a> (neuroleptics/antipsychotics) and <a href="../../../m/i/n/Minor_tranquilizers.html" title="Minor tranquilizers">minor tranquilizers</a> (benzodiazepines), which were being marketed for different uses. The term antidepressant is reported to have been coined by Lurie and to not have been widely adopted until at least the 1960s.<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[7]</a></sup> Imipramine remained in common use and numerous successors were introduced. The field of MAO inhibitors remained quiet for many years until "reversible" forms affecting only the MAO-A subtype were introduced, avoiding some of the adverse effects.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[8]</a></sup><sup id="_ref-8" class="reference"><a href="#_note-8" title="">[9]</a></sup></p>
<p>Most pharmacologists by the 1960s thought the main therapeutic action of tricyclics was to inhibit <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a> reuptake, but it was gradually observed that this action was associated with energizing and motor stimulating effects whilst some antidepressant compounds appeared to have differing effects through action on serotonin systems (notably proposed by Carlsson and Lindqvist (1969) and Lapin and Oxenkrug (1969)). Researchers began a process of <a href="../../../r/a/t/Rational_drug_design.html" title="Rational drug design">rational drug design</a> to isolate antihistamine-derived compounds that would 'selectively' (specifically) target these systems. The first such compound to be patented, in 1971, was <a href="../../../z/i/m/Zimelidine.html" title="Zimelidine">zimelidine</a>, whilst the first released clinically was indalpine. <a href="../../../f/l/u/Fluoxetine.html" title="Fluoxetine">Fluoxetine</a>, which from 1988 became the first <a href="../../../b/l/o/Blockbuster_drug.html" title="Blockbuster drug">blockbuster</a> <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRI</a> (<b>S</b>elective <b>S</b>erotonin <b>R</b>euptake <b>I</b>nhibitor) was developed at <a href="../../../e/l/i/Eli_Lilly_1e1b.html" title="Eli Lilly">Eli Lilly</a> in the early 1970s by Bryan Molloy, Ray Fuller, David Wong and others.<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[10]</a></sup><sup id="_ref-10" class="reference"><a href="#_note-10" title="">[11]</a></sup></p>
<p>While it had fallen out of favor in most countries through the 19th and 20th centuries, the herb <a href="../../../s/t/_/St_John%27s_Wort_98c1.html" title="St John's Wort">St John's Wort</a> had become increasingly popular in Germany where Hypericum extracts eventually became licensed, packaged and prescribed by doctors. Small-scale efficacy trials were carried out from the 1970s and 1980s, and attention grew in the 1990s following a <a href="../../../m/e/t/Meta-analysis.html" title="Meta-analysis">meta-analysis</a> of these.<sup id="_ref-11" class="reference"><a href="#_note-11" title="">[12]</a></sup> It remained an <a href="../../../o/v/e/Over-the-counter_drug.html" title="Over-the-counter drug">over-the-counter drug</a> or supplement in most countries, however, and research continued to investigate its neurotransmitter effects and active components, particularly <a href="../../../h/y/p/Hyperforin.html" title="Hyperforin">hyperforin</a><sup id="_ref-12" class="reference"><a href="#_note-12" title="">[13]</a></sup><sup id="_ref-13" class="reference"><a href="#_note-13" title="">[14]</a></sup></p>
<p>SSRI's became known as "novel antidepressants" along with other newer drugs with various different selective effects, such as <a href="../../../v/e/n/Venlafaxine.html" title="Venlafaxine">venlafaxine</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">nefazodone</a> and <a href="../../../m/i/r/Mirtazapine.html" title="Mirtazapine">mirtazapine</a><sup id="_ref-14" class="reference"><a href="#_note-14" title="">[15]</a></sup></p>
<p><a name="Classes_and_members" id="Classes_and_members"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Classes and members">edit</a>]</span> <span class="mw-headline">Classes and members</span></h2>
<p>The following clickable info-box is from the <a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">Anatomical Therapeutic Chemical Classification System</a> published by the <a href="../../../w/o/r/World_Health_Organization_57ba.html" title="World Health Organization">World Health Organization</a>. See also Wikipedia's <a href="../../../l/i/s/List_of_antidepressants.html" title="List of antidepressants">list of antidepressants</a>.</p>
<p><br /></p>
<table class="navbox collapsible" style="margin:auto; text-align=left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; width:6em; text-align:left;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../a/n/t/Template%7EAntidepressants_b6a6.html" title="Template:Antidepressants"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../a/n/t/Template_talk%7EAntidepressants_2d19.html" title="Template talk:Antidepressants"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../a/n/t/Template%7EAntidepressants_b6a6.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Template%7EAntidepressants_b6a6.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<span style="font-size:110%;"><strong class="selflink">Antidepressants</strong> (<a href="../../../a/t/c/ATC_code_N06_9c1c.html#N06A_Antidepressants" title="ATC code N06">ATC N06A</a>)</span></th>
</tr>
<tr>
<th style=""><a href="../../../m/o/n/Monoamine_oxidase_inhibitor.html" title="Monoamine oxidase inhibitor">Monoamine oxidase inhibitors</a> (MAOI)</th>
<td style="" colspan="1"><a href="../../../h/a/r/Harmaline.html" title="Harmaline">Harmaline</a>, <a href="../../../i/p/r/Iproniazid.html" title="Iproniazid">Iproniazid</a>, <a href="../../../i/s/o/Isocarboxazid.html" title="Isocarboxazid">Isocarboxazid</a>, <a href="../../../n/i/a/Nialamide.html" title="Nialamide">Nialamide</a>, <a href="../../../p/a/r/Pargyline.html" title="Pargyline">Pargyline</a>, <a href="../../../p/h/e/Phenelzine.html" title="Phenelzine">Phenelzine</a>, <a href="../../../s/e/l/Selegiline.html" title="Selegiline">Selegiline</a>, <a href="../../../t/o/l/Toloxatone.html" title="Toloxatone">Toloxatone</a>, <a href="../../../t/r/a/Tranylcypromine.html" title="Tranylcypromine">Tranylcypromine</a><br />
<i><a href="../../../r/e/v/Reversible_inhibitor_of_monoamine_oxidase_A_da48.html" title="Reversible inhibitor of monoamine oxidase A">RIMAs</a>:</i> <a href="../../../b/r/o/Brofaromine.html" title="Brofaromine">Brofaromine</a>, <a href="../../../m/o/c/Moclobemide.html" title="Moclobemide">Moclobemide</a></td>
</tr>
<tr>
<th style=""><a href="../../../d/o/p/Dopamine_reuptake_inhibitor.html" title="Dopamine reuptake inhibitor">Dopamine reuptake inhibitor</a> (DARI)</th>
<td style="" colspan="1"><a href="../../../a/m/i/Amineptine.html" title="Amineptine">Amineptine</a>, <a href="../../../p/h/e/Phenmetrazine.html" title="Phenmetrazine">Phenmetrazine</a>, <a href="../../../v/a/n/Vanoxerine.html" title="Vanoxerine">Vanoxerine</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Norepinephrine-dopamine_reuptake_inhibitor.html" title="Norepinephrine-dopamine reuptake inhibitor">Norepinephrine-dopamine reuptake inhibitors</a> (NDRI)</th>
<td style="" colspan="1"><a href="../../../b/u/p/Bupropion.html" title="Bupropion">Bupropion</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Norepinephrine_reuptake_inhibitor.html" title="Norepinephrine reuptake inhibitor">Norepinephrine reuptake inhibitor</a> (NRI) or (NARI)</th>
<td style="" colspan="1"><a href="../../../a/t/o/Atomoxetine.html" title="Atomoxetine">Atomoxetine</a>, <a href="../../../m/a/p/Maprotiline.html" title="Maprotiline">Maprotiline</a>, <a href="../../../r/e/b/Reboxetine.html" title="Reboxetine">Reboxetine</a>, <a href="../../../v/i/l/Viloxazine.html" title="Viloxazine">Viloxazine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/r/Serotonin-norepinephrine_reuptake_inhibitor.html" title="Serotonin-norepinephrine reuptake inhibitor">Serotonin-norepinephrine reuptake inhibitor</a> (SNRI)</th>
<td style="" colspan="1"><a href="../../../d/e/s/Desvenlafaxine.html" title="Desvenlafaxine">Desvenlafaxine</a>, <a href="../../../d/u/l/Duloxetine.html" title="Duloxetine">Duloxetine</a>, <a href="../../../m/i/l/Milnacipran.html" title="Milnacipran">Milnacipran</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">Nefazodone</a>, <a href="../../../v/e/n/Venlafaxine.html" title="Venlafaxine">Venlafaxine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/l/Selective_serotonin_reuptake_inhibitor.html" title="Selective serotonin reuptake inhibitor">Selective serotonin reuptake inhibitor</a> (SSRI)</th>
<td style="" colspan="1"><a href="../../../a/l/a/Alaproclate.html" title="Alaproclate">Alaproclate</a>, <a href="../../../c/i/t/Citalopram.html" title="Citalopram">Citalopram</a>, <a href="../../../e/s/c/Escitalopram.html" title="Escitalopram">Escitalopram</a>, <a href="../../../e/t/o/Etoperidone.html" title="Etoperidone">Etoperidone</a>, <a href="../../../f/l/u/Fluoxetine.html" title="Fluoxetine">Fluoxetine</a>, <a href="../../../f/l/u/Fluvoxamine.html" title="Fluvoxamine">Fluvoxamine</a>, <a href="../../../p/a/r/Paroxetine.html" title="Paroxetine">Paroxetine</a>, <a href="../../../s/e/r/Sertraline.html" title="Sertraline">Sertraline</a>, <a href="../../../z/i/m/Zimelidine.html" title="Zimelidine">Zimelidine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/l/Selective_serotonin_reuptake_enhancer.html" title="Selective serotonin reuptake enhancer">Selective serotonin reuptake enhancer</a> (SSRE)</th>
<td style="" colspan="1"><a href="../../../t/i/a/Tianeptine.html" title="Tianeptine">Tianeptine</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Noradrenergic_and_specific_serotonergic_antidepressant.html" title="Noradrenergic and specific serotonergic antidepressant">Noradrenergic and specific serotonergic antidepressant</a> (NaSSA)</th>
<td style="" colspan="1"><a href="../../../m/i/r/Mirtazapine.html" title="Mirtazapine">Mirtazapine</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/r/i/Tricyclic_antidepressant.html" title="Tricyclic antidepressant">Tricyclic antidepressants</a> (TCA)</th>
<td style="" colspan="1"><a href="../../../a/m/i/Amitriptyline.html" title="Amitriptyline">Amitriptyline</a>, <a href="../../../a/m/o/Amoxapine.html" title="Amoxapine">Amoxapine</a>, <a href="../../../b/u/t/Butriptyline.html" title="Butriptyline">Butriptyline</a>, <a href="../../../c/l/o/Clomipramine.html" title="Clomipramine">Clomipramine</a>, <a href="../../../d/e/s/Desipramine.html" title="Desipramine">Desipramine</a>, <a href="../../../d/i/b/Dibenzepin.html" title="Dibenzepin">Dibenzepin</a>, <a href="../../../d/o/s/Dosulepin_hydrochloride.html" title="Dosulepin hydrochloride">Dothiepin</a>, <a href="../../../d/o/x/Doxepin.html" title="Doxepin">Doxepin</a>, <a href="../../../i/m/i/Imipramine.html" title="Imipramine">Imipramine</a>, <a href="../../../i/p/r/Iprindole.html" title="Iprindole">Iprindole</a>, <a href="../../../l/o/f/Lofepramine.html" title="Lofepramine">Lofepramine</a>, <a href="../../../m/e/l/Melitracen.html" title="Melitracen">Melitracen</a>, <a href="../../../n/o/r/Nortriptyline.html" title="Nortriptyline">Nortriptyline</a>, <a href="../../../o/p/i/Opipramol.html" title="Opipramol">Opipramol</a>, <a href="../../../p/r/o/Protriptyline.html" title="Protriptyline">Protriptyline</a>, <a href="../../../t/r/i/Trimipramine.html" title="Trimipramine">Trimipramine</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/e/t/Tetracyclic_antidepressant.html" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a></th>
<td style="" colspan="1"><a href="../../../m/a/p/Maprotiline.html" title="Maprotiline">Maprotiline</a>, <a href="../../../m/i/a/Mianserin.html" title="Mianserin">Mianserin</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">Nefazodone</a>, <a href="../../../t/r/a/Trazodone.html" title="Trazodone">Trazodone</a></td>
</tr>
</table>
<p><a name="Prescription_trends" id="Prescription_trends"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Prescription trends">edit</a>]</span> <span class="mw-headline">Prescription trends</span></h2>
<p>A 1998 survey found that 67% of patients in the <a href="../../../u/n/i/United_States_09d4.html" title="United States">United States</a> diagnosed with depression had been prescribed an antidepressant.<sup id="_ref-15" class="reference"><a href="#_note-15" title="">[16]</a></sup>. A 2002 survey found that 3.5% of all people in <a href="../../../f/r/a/France.html" title="France">France</a> were being prescribed antidepressants, compared to 1.7% in 1992, often for conditions other than depression and often not in line with authorizations or guidelines<sup id="_ref-16" class="reference"><a href="#_note-16" title="">[17]</a></sup> Between 1996 and 2004 in <a href="../../../b/r/i/British_Columbia_90ec.html" title="British Columbia">British Columbia</a>, antidepressant use increased from 3.4% to 7.2% of the population<sup id="_ref-17" class="reference"><a href="#_note-17" title="">[18]</a></sup> Data from the <a href="../../../n/e/t/Netherlands.html" title="Netherlands">Netherlands</a> indicated an increasing rate of prescriptions of SSRIs, and an increasing duration of treatment.<sup id="_ref-18" class="reference"><a href="#_note-18" title="">[19]</a></sup> Surveys indicate that antidepressant use, particularly of SSRIs, has increased rapidly in most developed countries, driven by an increased awareness of depression together with the availability and promotion of new antidepressants.<sup id="_ref-19" class="reference"><a href="#_note-19" title="">[20]</a></sup> The choice of particular antidepressant is reported to be based, in the absence of research evidence of differences in efficacy, on seeking to avoid certain side effects, and taking into account comorbid (co-occurring) psychiatric disorders, specific clinical symptoms and prior treatment history<sup id="_ref-20" class="reference"><a href="#_note-20" title="">[21]</a></sup> It is also reported that, despite lack of evidence of a significant difference in efficacy between older and newer antidepressants, clinicians perceive the newer drugs, including SSRIs, to be more effective than the older drugs (tricyclics and MAOIs).<sup id="_ref-21" class="reference"><a href="#_note-21" title="">[22]</a></sup> A survey in the UK found that male general physicians were more likely to prescribe antidepressants than female doctors.<sup id="_ref-22" class="reference"><a href="#_note-22" title="">[23]</a></sup></p>
<p><a name="Most_commonly_prescribed_antidepressants" id="Most_commonly_prescribed_antidepressants"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Most commonly prescribed antidepressants">edit</a>]</span> <span class="mw-headline">Most commonly prescribed antidepressants</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="../../../e/s/c/Image%7EEscitalopram2.png_e63e.html" class="internal" title="Structural formula of the SSRI escitalopram, in its free base form."><img src="../../../upload/shared/thumb/c/c9/Escitalopram2.png/250px-Escitalopram2.png" alt="Structural formula of the SSRI escitalopram, in its free base form." width="250" height="194" longdesc="../../../e/s/c/Image%7EEscitalopram2.png_e63e.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../e/s/c/Image%7EEscitalopram2.png_e63e.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Structural formula of the SSRI escitalopram, in its free base form.</div>
</div>
</div>
<p>The most commonly prescribed antidepressants in the US in 2005<a href="http://www.rxlist.com/top200.htm" class="external autonumber" title="http://www.rxlist.com/top200.htm" rel="nofollow">[4]</a>) were:</p>
<ul>
<li><a href="../../../s/e/r/Sertraline.html" title="Sertraline">Sertraline</a> - of the <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRI</a> class (e.g. <i>Zoloft, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton</i>)</li>
<li><a href="../../../e/s/c/Escitalopram.html" title="Escitalopram">Escitalopram</a> - of the <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRI</a> class (e.g. <i>Lexapro, Cipralex</i>)</li>
<li><a href="../../../f/l/u/Fluoxetine.html" title="Fluoxetine">Fluoxetine</a> - of the <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRI</a> class (e.g. <i>Prozac, Sarafem, Fluctin, Fontex, Prodep, Fludep, Lovan</i>)</li>
<li><a href="../../../v/e/n/Venlafaxine.html" title="Venlafaxine">Venlafaxine</a> - of the <a href="../../../s/n/r/SNRI_2dcc.html" title="SNRI">SNRI</a> class (e.g. <i>Effexor XR, Efexor</i>)</li>
<li><a href="../../../c/i/t/Citalopram.html" title="Citalopram">Citalopram</a> - of the <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRI</a> class (e.g. <i>Celexa, Cipramil, Talohexane</i>)</li>
<li><a href="../../../p/a/r/Paroxetine.html" title="Paroxetine">Paroxetine</a> - of the <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRI</a> class (e.g. <i>Paxil, Seroxat, Aropax</i>)</li>
<li><a href="../../../t/r/a/Trazodone.html" title="Trazodone">Trazodone</a> - of the <a href="../../../t/e/t/Tetracyclic_antidepressant.html" title="Tetracyclic antidepressant">Tetracyclic</a> class (e.g. <i>Desyrel</i>, <i>Trazolan</i>)</li>
<li><a href="../../../a/m/i/Amitriptyline.html" title="Amitriptyline">Amitriptyline</a> - of the <a href="../../../t/r/i/Tricyclic_antidepressant.html" title="Tricyclic antidepressant">TCA</a> class (e.g. <i>Elavil</i>)</li>
<li><a href="../../../b/u/p/Bupropion.html" title="Bupropion">Bupropion</a> - of the <a href="../../../d/o/p/Dopamine_reuptake_inhibitor.html" title="Dopamine reuptake inhibitor">DRI</a> and <a href="../../../n/o/r/Norepinephrine_reuptake_inhibitor.html" title="Norepinephrine reuptake inhibitor">NRI</a> classes (e.g. <i>Wellbutrin, Zyban</i>)</li>
</ul>
<p>The most commonly prescribed antidepressant in Germany is reported to be (concentrated extracts of) hypericum perforatum (St John's Wort).<a href="http://www.gardenguides.com/plants/info/herbs/sjwort.asp" class="external autonumber" title="http://www.gardenguides.com/plants/info/herbs/sjwort.asp" rel="nofollow">[5]</a></p>
<p><a name="Mechanisms_of_action" id="Mechanisms_of_action"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Mechanisms of action">edit</a>]</span> <span class="mw-headline">Mechanisms of action</span></h2>
<p>The therapeutic effects of antidepressants are believed to be related to their effects on <a href="../../../n/e/u/Neurotransmitter.html" title="Neurotransmitter">neurotransmitters</a>. <a href="../../../m/o/n/Monoamine_oxidase_inhibitor.html" title="Monoamine oxidase inhibitor">Monoamine oxidase inhibitors</a> (MAOIs) block the break-down of monoamine neurotransmitters (<a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonin</a> and <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a>) by inhibiting the <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzymes</a> which oxidize them, thus leaving higher levels still active in the brain. Tricyclic antidepressants (TCAs) prevent the reuptake of various <a href="../../../n/e/u/Neurotransmitters.html" title="Neurotransmitters">neurotransmitters</a>, including <a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonin</a>, <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a>, and <a href="../../../d/o/p/Dopamine.html" title="Dopamine">dopamine</a>. <a href="../../../s/e/l/Selective_serotonin_reuptake_inhibitor.html" title="Selective serotonin reuptake inhibitor">Selective serotonin reuptake inhibitors</a> (SSRIs) more specifically prevent the reuptake of serotonin (thereby increasing the level of active serotonin in <a href="../../../s/y/n/Synapse.html" title="Synapse">synapses</a> of the <a href="../../../b/r/a/Brain.html" title="Brain">brain</a>). Other novel antidepressants specifically affect serotonin and other neurotransmitters.</p>
<p>A theory centered on neurotransmitter effects appears to be incomplete, however. Neurotransmitter levels are altered as soon as the antidepressant chemicals build up in the bloodstream, but effects on mood appear to occur several days or weeks later. One explanation of this holds that the "<a href="../../../d/o/w/Down-regulation.html" title="Down-regulation">down-regulation</a>" of neurotransmitter <a href="../../../t/r/a/Transmembrane_receptor.html" title="Transmembrane receptor">receptors</a>— an apparent consequence of excess signaling and a process that takes several weeks — is actually the mechanism responsible for the alleviation of depressive symptoms. Another hypothesis is that antidepressants may have some longer-term effects due to the promotion of <a href="../../../n/e/u/Neurogenesis.html" title="Neurogenesis">neurogenesis</a> in the <a href="../../../h/i/p/Hippocampus.html" title="Hippocampus">hippocampus</a>, an effect found in mice <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11124987&amp;query_hl=4" class="external autonumber" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11124987&amp;query_hl=4" rel="nofollow">[6]</a><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11137860&amp;query_hl=2" class="external autonumber" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11137860&amp;query_hl=2" rel="nofollow">[7]</a>. Other animal research suggests that antidepressants can also effect the expression of genes in brain cells, by influencing "clock genes" <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15994025&amp;query_hl=24" class="external autonumber" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15994025&amp;query_hl=24" rel="nofollow">[8]</a>.</p>
<p><a name="Anti-inflammatory_and_Immunomodulation" id="Anti-inflammatory_and_Immunomodulation"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Anti-inflammatory and Immunomodulation">edit</a>]</span> <span class="mw-headline">Anti-inflammatory and Immunomodulation</span></h3>
<p>Recent studies show pro-inflammatory <a href="../../../c/y/t/Cytokine.html" title="Cytokine">cytokine</a> processes take place during <a href="../../../c/l/i/Clinical_depression.html" title="Clinical depression">depression</a>, <a href="../../../m/a/n/Mania.html" title="Mania">mania</a> and <a href="../../../b/i/p/Bipolar_disorder.html" title="Bipolar disorder">bipolar</a> disease, and is possible that symptoms manifest in these psychiatric illnesses are being attenuated by pharmacological affect of antidepressants on the immune system.<sup id="_ref-23" class="reference"><a href="#_note-23" title="">[24]</a></sup><sup id="_ref-24" class="reference"><a href="#_note-24" title="">[25]</a></sup><sup id="_ref-25" class="reference"><a href="#_note-25" title="">[26]</a></sup><sup id="_ref-26" class="reference"><a href="#_note-26" title="">[27]</a></sup><sup id="_ref-27" class="reference"><a href="#_note-27" title="">[28]</a></sup></p>
<p>Studies also show that the chronic secretion of <a href="../../../s/t/r/Stress.html" title="Stress">stress</a> <a href="../../../h/o/r/Hormones.html" title="Hormones">hormones</a> as a result of disease, including <a href="../../../s/o/m/Somatic.html" title="Somatic">somatic</a> <a href="../../../i/n/f/Infections.html" title="Infections">infections</a> or <a href="../../../a/u/t/Autoimmune.html" title="Autoimmune">autoimmune</a> syndromes may reduce the affect of <a href="../../../n/e/u/Neurotransmitters.html" title="Neurotransmitters">neurotransmitters</a> or other receptors in the brain by <a href="../../../c/e/l/Cell-mediated_immunity.html" title="Cell-mediated immunity">cell-mediated</a> pro-inflammatory pathways, thereby leading to the dysregulation of neurohormones.<sup id="_ref-28" class="reference"><a href="#_note-28" title="">[29]</a></sup> <a href="../../../s/s/r/SSRI_b98a.html" title="SSRI">SSRI's</a>, <a href="../../../s/n/r/SNRI_2dcc.html" title="SNRI">SNRI's</a> and <a href="../../../t/r/i/Tricyclic.html" title="Tricyclic">tricyclic</a> <a href="../../../a/n/t/Antidepressants.html" title="Antidepressants">antidepressants</a> acting on <a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonin</a>, <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a> and <a href="../../../d/o/p/Dopamine.html" title="Dopamine">dopamine</a> receptors have been shown to be immunomodulatory and anti-inflammatory against pro-inflammatory <a href="../../../c/y/t/Cytokine.html" title="Cytokine">cytokine</a> processes, specifically on the regulation of <a href="../../../i/n/t/Interferon-gamma.html" title="Interferon-gamma">Interferon-gamma</a> (IFN-gamma) and <a href="../../../i/n/t/Interleukin-10.html" title="Interleukin-10">Interleukin-10</a> (IL-10), as well as <a href="../../../t/n/f/TNF-alpha_8298.html" title="TNF-alpha">TNF-alpha</a> and <a href="../../../i/n/t/Interleukin-6.html" title="Interleukin-6">Interleukin-6</a> (IL-6). Antidepressants have also been shown to suppress <a href="../../../t/h/1/TH1_222d.html" title="TH1">TH1</a> upregulation.<sup id="_ref-29" class="reference"><a href="#_note-29" title="">[30]</a></sup><sup id="_ref-30" class="reference"><a href="#_note-30" title="">[31]</a></sup><sup id="_ref-31" class="reference"><a href="#_note-31" title="">[32]</a></sup><sup id="_ref-32" class="reference"><a href="#_note-32" title="">[33]</a></sup><sup id="_ref-33" class="reference"><a href="#_note-33" title="">[34]</a></sup> These studies warrant investigation for antidepressants for use in both psychiatric and non-psychiatric illness and that a psycho-neuroimmunological approach may be required for optimal <a href="../../../p/h/a/Pharmacotherapy.html" title="Pharmacotherapy">pharmacotherapy</a>.<sup id="_ref-34" class="reference"><a href="#_note-34" title="">[35]</a></sup></p>
<p>Future antidepressants may be made to specifically target the immune system by either blocking the actions of pro-inflammatory cytokines or increasing the production of anti-inflammatory cytokines.<sup id="_ref-35" class="reference"><a href="#_note-35" title="">[36]</a></sup></p>
<p><a name="Therapeutic_efficacy" id="Therapeutic_efficacy"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Therapeutic efficacy">edit</a>]</span> <span class="mw-headline">Therapeutic efficacy</span></h2>
<p>There is a large amount of research evaluating the potential therapeutic effects of antidepressants, whether through efficacy studies under experimental conditions (including randomized clinical trials) or through studies of "real world" effectiveness. A sufficient <i>response</i> to a drug is often defined as at least a 50% reduction in self-reported or observed symptoms, with a <i>partial response</i> often defined as at least a 25% reduction. The term <i>remission</i> indicates a virtual elimination of depression symptoms, albeit with the risk of a <i>recurrence</i> of symptoms or complete <i>relapse</i>. Full remission or <i>recovery</i> signifies a full sustained return to a "normal" psychological state with full functioning.</p>
<p><a name="Review_studies" id="Review_studies"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Review studies">edit</a>]</span> <span class="mw-headline">Review studies</span></h3>
<div class="messagebox cleanup metadata plainlinks">
<table style="width:99%;background:none">
<tr>
<td width="60px"><a href="../../../w/i/k/Image%7EWiki_letter_w.svg_e974.html" class="image" title=""><img src="../../../upload/shared/thumb/6/6c/Wiki_letter_w.svg/45px-Wiki_letter_w.svg.png" alt="" width="45" height="45" longdesc="../../../w/i/k/Image%7EWiki_letter_w.svg_e974.html" /></a></td>
<td><b>Please help <a href="http://en.wikipedia.org../../../a/n/t/Antidepressant.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Antidepressant.html" rel="nofollow">improve this article</a> by expanding this section.</b><br />
<small>Further information might be found on the <a href="../../../a/n/t/Talk%7EAntidepressant_3281.html" title="Talk:Antidepressant">talk page</a> or at <a href="../../../r/e/q/Wikipedia%7ERequests_for_expansion_6da0.html" title="Wikipedia:Requests for expansion">requests for expansion</a>. Please remove this message once the section has been expanded.<br />
This article has been tagged since <b>January 2007</b>.</small></td>
</tr>
</table>
</div>
<p>Recent clinical reviews include:</p>
<ul>
<li>A comparison of the relative efficacy of different classes of antidepressants<sup id="_ref-36" class="reference"><a href="#_note-36" title="">[37]</a></sup> in different settings<sup id="_ref-37" class="reference"><a href="#_note-37" title="">[38]</a></sup> and in regard to different kinds of depression<sup id="_ref-38" class="reference"><a href="#_note-38" title="">[39]</a></sup></li>
</ul>
<ul>
<li>An assessment of antidepressants compared with an "active placebo"<sup id="_ref-39" class="reference"><a href="#_note-39" title="">[40]</a></sup></li>
</ul>
<ul>
<li>An assessment of the newer types of the MAOI class<sup id="_ref-40" class="reference"><a href="#_note-40" title="">[41]</a></sup></li>
</ul>
<ul>
<li>A meta-analysis of randomized trials of St John's Wort<sup id="_ref-41" class="reference"><a href="#_note-41" title="">[42]</a></sup></li>
</ul>
<ul>
<li>A review of the use of antidepressants for childhood depression<sup id="_ref-42" class="reference"><a href="#_note-42" title="">[43]</a></sup></li>
</ul>
<p><a name="Clinical_guidelines" id="Clinical_guidelines"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Clinical guidelines">edit</a>]</span> <span class="mw-headline">Clinical guidelines</span></h3>
<p>The <a href="../../../a/m/e/American_Psychiatric_Association_f5df.html" title="American Psychiatric Association">American Psychiatric Association</a> 2000 Practice Guideline for the Treatment of Patients with Major Depressive Disorder<a href="http://www.guidelines.gov/summary/summary.aspx?doc_id=2605&amp;nbr=1831" class="external autonumber" title="http://www.guidelines.gov/summary/summary.aspx?doc_id=2605&amp;nbr=1831" rel="nofollow">[9]</a> indicates that, if preferred by the patient, antidepressant medications may be provided as an initial primary treatment for mild major depressive disorder; antidepressant medications should be provided for moderate to severe major depressive disorder unless <a href="../../../e/l/e/Electroconvulsive_therapy.html" title="Electroconvulsive therapy">electroconvulsive therapy</a> is planned; and a combination of antipsychotic and antidepressant medications or electroconvulsive therapy should be used for psychotic depression. It states that efficacy is generally comparable between classes and within classes and that the initial selection will largely be based on the anticipated side effects for an individual patient, patient preference, quantity and quality of clinical trial data regarding the medication, and its cost.</p>
<p>The UK <a href="../../../n/a/t/National_Institute_for_Clinical_Excellence_c4aa.html" title="National Institute for Clinical Excellence">National Institute for Clinical Excellence</a> (NICE) 2004 guidelines indicate that antidepressants should not be used for the initial treatment of mild depression, because the risk-benefit ratio is poor; that for moderate or severe depression an SSRI is more likely to be tolerated than a tricyclic; and that antidepressants for severe depression should be combined with a psychological treatment such as <a href="../../../c/o/g/Cognitive_Behavioural_Therapy_ff97.html" title="Cognitive Behavioural Therapy">Cognitive Behavioural Therapy</a>.<a href="http://www.nice.org.uk/guidance/CG23" class="external autonumber" title="http://www.nice.org.uk/guidance/CG23" rel="nofollow">[10]</a></p>
<p><a name="Efficacy_limitations_and_strategies" id="Efficacy_limitations_and_strategies"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Efficacy limitations and strategies">edit</a>]</span> <span class="mw-headline">Efficacy limitations and strategies</span></h3>
<p>Between 30% and 50% of individuals treated with a given antidepressant do not show a response.<sup id="_ref-43" class="reference"><a href="#_note-43" title="">[44]</a></sup><sup id="_ref-SSRIswitch_0" class="reference"><a href="#_note-SSRIswitch" title="">[45]</a></sup> Even where there has been a robust response, significant continuing depression and dysfunction is common, with relapse rates 3 to 6 times higher in such cases.<sup id="_ref-44" class="reference"><a href="#_note-44" title="">[46]</a></sup> In addition, antidepressant drugs tend to lose efficacy over the course of treatment<sup id="_ref-45" class="reference"><a href="#_note-45" title="">[47]</a></sup> A number of strategies are used in clinical practice to try to overcome these limits and variations.<sup id="_ref-46" class="reference"><a href="#_note-46" title="">[48]</a></sup></p>
<p><a name=".22Trial_and_error.22_switching"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: &quot;Trial and error&quot; switching">edit</a>]</span> <span class="mw-headline">"Trial and error" switching</span></h4>
<p>The <a href="../../../a/m/e/American_Psychiatric_Association_f5df.html" title="American Psychiatric Association">American Psychiatric Association</a> 2000 Practice Guideline advises that where no response is achieved following six to eight weeks of treatment with an antidepressant, to switch to an antidepressant in the same class, then to a different class of antidepressant.</p>
<p>A recent meta-analysis review found wide variation in the findings of prior studies; for patients who had failed to respond to an SSRI antidepressant, between 12% and 86% showed a response to a new drug, with between 5% and 39% ending treatment due to adverse effects. The more antidepressants an individual had already tried, the less likely they were to benefit from a new antidepressant trial.<sup id="_ref-SSRIswitch_1" class="reference"><a href="#_note-SSRIswitch" title="">[45]</a></sup></p>
<p><a name="Augmentation_and_Combination" id="Augmentation_and_Combination"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Augmentation and Combination">edit</a>]</span> <span class="mw-headline">Augmentation and Combination</span></h4>
<p>For a partial response, the American Psychiatric Association guidelines advise adding a different kind of pharmaceutical agent to the antidepressant. Studies suggest that most patients fail to achieve remission on a given antidepressant, and augmentation strategies used in clinical practice include the use of <a href="../../../l/i/t/Lithium.html" title="Lithium">lithium</a> and <a href="../../../t/h/y/Thyroid.html" title="Thyroid">thyroid</a> augmentation, but there is not a good evidence base for these practices or for more novel strategies such as the use of selective dopamine agonists, <a href="../../../s/e/x/Sex_steroids.html" title="Sex steroids">sex steroids</a>, norepinephrine reuptake inhibitors, glucocorticoid-specific agents, or the newer <a href="../../../a/n/t/Anticonvulsants.html" title="Anticonvulsants">anticonvulsants</a><sup id="_ref-augment_0" class="reference"><a href="#_note-augment" title="">[49]</a></sup></p>
<p>A combination strategy involves adding one or more additional antidepressants, usually from different classes so as to have a diverse neurochemical effect. Although this may be used in clinical practice, there is little evidence for the relative efficacy or adverse effects of this strategy.<sup id="_ref-47" class="reference"><a href="#_note-47" title="">[50]</a></sup></p>
<p><a name="Long-term_use" id="Long-term_use"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Long-term use">edit</a>]</span> <span class="mw-headline">Long-term use</span></h4>
<p>The therapeutic effects of antidepressants typically do not continue once the course of medication ends, resulting in a high rate of relapse. A recent meta-analysis of 31 placebo-controlled antidepressant trials, mostly limited to studies covering a period of one year, found that 18% of patients who had responded to an antidepressant relapsed while still taking it, compared to 41% whose antidepressant was switched for a placebo.<sup id="_ref-48" class="reference"><a href="#_note-48" title="">[51]</a></sup> The American Psychiatric Association guidelines advise four to five months of continuation treatment on an antidepressant following the resolution of symptoms. For patients with a history of depressive episodes, the British Association for Psychopharmacology's 2000 Guidelines for Treating Depressive Disorders with Antidepressants advise remaining on an antidepressant for at least six months and as long as five years or indefinitely.</p>
<p>Whether or not someone relapses after stopping an antidepressant does not appear to be related to the duration of prior treatment, however, and gradual loss of therapeutic benefit during the course also occurs. A strategy involving the use of pharmacotherapy in the treatment of the acute episode, followed by psychotherapy in its residual phase, has been suggested by some studies.<sup id="_ref-49" class="reference"><a href="#_note-49" title="">[52]</a></sup><sup id="_ref-50" class="reference"><a href="#_note-50" title="">[53]</a></sup></p>
<p><a name="Tolerance_and_dependence" id="Tolerance_and_dependence"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Tolerance and dependence">edit</a>]</span> <span class="mw-headline">Tolerance and dependence</span></h2>
<p>Most antidepressants, including the SSRIs and tricyclics, are known to produce <a href="../../../d/r/u/Drug_tolerance.html" title="Drug tolerance">tolerance</a> (i.e. a patient receiving antidepressant therapy for some years will often have to increase the dose over time, or add other drugs, to receive the same therapeutic effect), and <a href="../../../w/i/t/Withdrawal.html" title="Withdrawal">withdrawal</a> (particularly if abrupt) may produce adverse effects, which can range from mild to extremely severe.</p>
<p>Antidepressants do not seem to have all of the same <a href="../../../a/d/d/Addiction.html" title="Addiction">addictive</a> qualities as other substances such as <a href="../../../n/i/c/Nicotine.html" title="Nicotine">nicotine</a>, <a href="../../../c/a/f/Caffeine.html" title="Caffeine">caffeine</a>, <a href="../../../c/o/c/Cocaine.html" title="Cocaine">cocaine</a>, or other <a href="../../../s/t/i/Stimulant.html" title="Stimulant">stimulants</a> - in other words, while antidepressants may cause dependence and withdrawal they do not seem to cause uncontrollable urges to increase the dose due to <a href="../../../e/u/p/Euphoria.html" title="Euphoria">euphoria</a> or <a href="../../../p/l/e/Pleasure.html" title="Pleasure">pleasure</a>, and thus do not meet the strict definition of an addictive substance. However, antidepressants do meet the <a href="../../../w/o/r/World_Health_Organisation_e337.html" title="World Health Organisation">World Health Organisation</a> definition of "dependency-inducing", and indeed the SSRIs are listed by the organisation as among the most strongly dependency-inducing substances in existence.</p>
<p>If an <a href="../../../s/e/l/Selective_serotonin_reuptake_inhibitor.html" title="Selective serotonin reuptake inhibitor">SSRI</a> medication is suddenly discontinued, it may produce both <a href="../../../w/i/t/Withdrawal.html" title="Withdrawal">somatic</a> and <a href="../../../a/d/d/Addiction.html" title="Addiction">psychological withdrawal</a> symptoms, a phenomenon known as "<a href="../../../s/s/r/SSRI_discontinuation_syndrome_cbb3.html" title="SSRI discontinuation syndrome">SSRI discontinuation syndrome</a>" (Tamam &amp; Ozpoyraz, 2002). When the decision is made to stop taking antidepressants it is common practice to "wean" off of them by slowly decreasing the dose over a period of several weeks or months, although often this will reduce the severity of the discontinuation reaction, rather than prevent it. Most cases of discontinuation syndrome last between one and four weeks, though there are examples of patients (especially those who have used the drugs for longer periods of time, or at a higher dose) experiencing adverse effects such as impaired concentration, poor short-term memory, elevated anxiety and sexual dysfunction, for months or even years after discontinuation.</p>
<p>It is generally not a good idea to take antidepressants without a prescription. The selection of an antidepressant and dosage suitable for a certain case and a certain person is a lengthy and complicated process, requiring the knowledge of a professional. Certain antidepressants can initially make depression worse, can induce <a href="../../../a/n/x/Anxiety.html" title="Anxiety">anxiety</a>, or can make a patient aggressive, dysphoric or acutely <a href="../../../s/u/i/Suicidal.html" title="Suicidal">suicidal</a>. In certain cases, an antidepressant can induce a switch from depression to <a href="../../../m/a/n/Mania.html" title="Mania">mania</a> or <a href="../../../h/y/p/Hypomania.html" title="Hypomania">hypomania</a>, can accelerate and shorten a manic cycle (i.e. promote a rapid-cycling pattern), or can induce the development of <a href="../../../p/s/y/Psychosis.html" title="Psychosis">psychosis</a> (or just the re-activation of latent psychosis) in a patient with depression who wasn't psychotic before the antidepressant.</p>
<p><a name="Side_effects" id="Side_effects"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Side effects">edit</a>]</span> <span class="mw-headline">Side effects</span></h2>
<p>Antidepressants can often cause <a href="../../../a/d/v/Adverse_drug_reaction.html" title="Adverse drug reaction">side effects</a>, and an inability to tolerate these is the most common cause of discontinuing an otherwise working medication.</p>
<p>Side effects of SSRIs: <a href="../../../n/a/u/Nausea.html" title="Nausea">Nausea</a>, <a href="../../../d/i/a/Diarrhea.html" title="Diarrhea">diarrhea</a>, <a href="../../../h/e/a/Headache.html" title="Headache">headaches</a>. Sexual side effects are also common with SSRIs, such as loss of <a href="../../../l/i/b/Libido.html" title="Libido">libido</a>, failure to reach <a href="../../../o/r/g/Orgasm.html" title="Orgasm">orgasm</a> and erectile problems. <a href="../../../s/e/r/Serotonin_syndrome.html" title="Serotonin syndrome">Serotonin syndrome</a> is also a worrying condition associated with the use of SSRIs. The Food and Drug Administration has included Black Box warnings on all SSRIs stating how they double suicidality (from 2 in 1,000 to 4 in 1,000) in children and adolescents who are prescribed these drugs.</p>
<p>Side effects of TCAs (tricyclic antidepressants): Fairly common side effects include dry mouth, blurred vision, <a href="../../../d/r/o/Drowsiness.html" title="Drowsiness">drowsiness</a>, <a href="../../../d/i/z/Dizziness.html" title="Dizziness">dizziness</a>, tremors, sexual problems, <a href="../../../s/k/i/Skin_rash.html" title="Skin rash">skin rash</a>, and weight gain or loss.</p>
<p>Side effects of MAOIs (monoamine oxidase inhibitors): Rare side effects of MAOIs like <a href="../../../p/h/e/Phenelzine.html" title="Phenelzine">phenelzine</a> (brand name: Nardil) and <a href="../../../t/r/a/Tranylcypromine.html" title="Tranylcypromine">tranylcypromine</a> (brand name: Parnate) include liver inflammation, <a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">heart attack</a>, <a href="../../../s/t/r/Stroke.html" title="Stroke">stroke</a>, and <a href="../../../s/e/i/Seizures.html" title="Seizures">seizures</a>.</p>
<p><a name="General" id="General"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: General">edit</a>]</span> <span class="mw-headline">General</span></h3>
<p>Although recent drugs may have fewer side effects, patients sometimes report severe side effects associated with their discontinuation, particularly with <a href="../../../p/a/r/Paroxetine.html" title="Paroxetine">paroxetine</a> and <a href="../../../v/e/n/Venlafaxine.html" title="Venlafaxine">venlafaxine</a><sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since January 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup>. Additionally, a certain percentage of patients do not respond to antidepressant drugs. Another advantage of some newer antidepressants is they can show effects within as few as five days, whereas most take four to six weeks to show a change in mood. However, some studies show that these medications might be even more likely to result in moderate to severe sexual dysfunction. However, there are medications in trials that appear to show an improved profile in regard to sexual dysfunction and other key side effects.</p>
<p>MAO inhibitors can produce a potentially lethal hypertensive reaction if taken with foods that contain high levels of <a href="../../../t/y/r/Tyramine.html" title="Tyramine">tyramine</a>, such as mature cheese, cured meats or yeast extracts. Likewise, lethal reactions to both prescription and over the counter medications have occurred. Any patient currently undergoing therapy with an MAO inhibiting medication should be monitored closely by the prescribing physician and always consulted before taking an over the counter or prescribed medication. Such patients should also inform emergency room personnel and information should be kept with one's identification indicating the fact that the holder is on MAO inhibiting medications. Some doctors even suggest the use of a medical alert ID bracelet. Although the reactions in question are dramatic when they happen, the total number of deaths due to interactions and dietary concerns are comparable to over-the-counter medications.</p>
<p>Antidepressants should be used with great care, usually in conjunction with <a href="../../../m/o/o/Mood_stabilisers.html" title="Mood stabilisers">mood stabilisers</a>, in the treatment of <a href="../../../b/i/p/Bipolar_disorder.html" title="Bipolar disorder">bipolar disorder</a>, as they can exacerbate symptoms of <a href="../../../m/a/n/Mania.html" title="Mania">mania</a>. They have also been known to trigger <a href="../../../m/a/n/Mania.html" title="Mania">mania</a> or <a href="../../../h/y/p/Hypomania.html" title="Hypomania">hypomania</a> in some patients with bipolar disorder and in a small percentage of patients with depression.<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9387089&amp;dopt=Abstract" class="external autonumber" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9387089&amp;dopt=Abstract" rel="nofollow">[11]</a> SSRIs are the antidepressants most frequently associated with this side effect.</p>
<p>Use of antidepressants should be monitored by a psychiatrist, but in countries such as <a href="../../../f/r/a/France.html" title="France">France</a>, <a href="../../../n/e/w/New_Zealand_2311.html" title="New Zealand">New Zealand</a>, the <a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">United Kingdom</a>, and the United States, primary care physicians are able to prescribe antidepressants without consulting a psychiatrist. In particular, it has been noted that the most dangerous period for <a href="../../../s/u/i/Suicide.html" title="Suicide">suicide</a> in a patient with depression is immediately after treatment has commenced, as antidepressants may reduce the symptoms of depression such as <a href="../../../p/s/y/Psychomotor_retardation.html" title="Psychomotor retardation">psychomotor retardation</a> or lack of motivation before mood starts to improve. Although this appears to be a paradox, studies indicate the suicidal ideation is a relatively common component of the initial phases of antidepressant therapy, and it may be even more prevalent in younger patients such as pre-adolescents and teenagers. It is strongly recommended that other family members and loved ones monitor the young patient's behavior, especially in the first eight weeks of therapy, for any signs of suicidal ideation or behaviors. Until the black box warnings on these drugs were issued by FDA as well as by agencies in other nations, side effects and alerting families to risk were largely ignored and downplayed by manufacturers and practitioners. This may have resulted in some deaths by suicide although direct proof for such a link is largely anecdotal. The higher incidence of suicide ideation reported in a number of studies has drawn attention and caution in how these drugs are used.</p>
<p>People under the age of 24 who suffer from depression are warned that the use of antidepressants could increase the risk of suicidal thoughts and behaviour. Federal health officials unveiled <a href="http://www.ecanadanow.com/science/health/2006/12/13/fda-antidepressants-increase-suicidal-risk-for-young-adults/" class="external text" title="http://www.ecanadanow.com/science/health/2006/12/13/fda-antidepressants-increase-suicidal-risk-for-young-adults/" rel="nofollow">Proposed changes</a> to the labels on antidepressant drugs in December 2006 to warn people of the inherent danger.</p>
<p><a name="Sexual" id="Sexual"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Sexual">edit</a>]</span> <span class="mw-headline">Sexual</span></h3>
<p><a href="../../../s/e/x/Sexual_dysfunction.html" title="Sexual dysfunction">Sexual dysfunction</a> is a very common side effect, especially with <a href="../../../s/e/l/Selective_serotonin_reuptake_inhibitor.html" title="Selective serotonin reuptake inhibitor">SSRIs</a>. Although usually reversible, these sexual side effects can, in rare cases, last for months or years after the drug has been completely withdrawn. This disorder is known as <a href="../../../p/o/s/Post_SSRI_Sexual_Dysfunction_34fa.html" title="Post SSRI Sexual Dysfunction">Post SSRI Sexual Dysfunction</a>. <a href="../../../b/u/p/Bupropion.html" title="Bupropion">Bupropion</a>, a dual reuptake inhibitor (NE and DA), in many cases results in a moderately increased libido, due to increased dopamine activity. This effect is also seen with dopamine reuptake inhibitors, CNS stimulants and dopamine agonists, and is due to increases in testosterone production (due to inhibition of prolactin) and increased nitric oxide synthesis. <a href="../../../a/p/o/Apomorphine.html" title="Apomorphine">Apomorphine</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">nefazodone</a> and <a href="../../../n/i/t/Nitroglycerin.html" title="Nitroglycerin">nitroglycerin</a> have been shown to reverse some sexual dysfunction via increased nitric oxide activity. <a href="../../../m/a/o/MAOI_edbc.html" title="MAOI">MAOIs</a> are reported to have fewer negative effects on sexual function and libido, particularly <a href="../../../m/o/c/Moclobemide.html" title="Moclobemide">moclobemide</a> at a 1.9% rate of occurrence. Betanechol has been reported to reverse MAOI-induced sexual dysfunction via its cholinergic agonist properties <sup>(Gross 1982)</sup>.</p>
<p>In order for the physician to select the appropriate response, the patient should provide the physician with information to distinguish between reduced libido (little or no desire for sex), reduced sexual function (<a href="../../../i/m/p/Impotence.html" title="Impotence">impotence</a>, vaginal dryness) and <a href="../../../a/n/o/Anorgasmia.html" title="Anorgasmia">anorgasmia</a>, as these have separate causes and prompt different treatment.</p>
<p><a name="Thymoanesthesia" id="Thymoanesthesia"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Thymoanesthesia">edit</a>]</span> <span class="mw-headline">Thymoanesthesia</span></h3>
<p>Closely related to sexual side effects is the phenomenon of emotional blunting, or mood anesthesia. Many users of SSRIs complain of apathy, lack of motivation, emotional numbness, feelings of detachment, and indifference to surroundings. They may describe this as a feeling of "not caring about anything any more." All SSRIs, SNRIs, and serotonergic TCAs are liable to cause this effect to varying degrees, especially at higher dosages.</p>
<p><a name="REM_Sleep" id="REM_Sleep"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: REM Sleep">edit</a>]</span> <span class="mw-headline">REM Sleep</span></h3>
<p>It is well recognized that virtually all major antidepressant drugs suppress <a href="../../../r/e/m/REM_sleep_0a73.html" title="REM sleep">REM sleep</a> and it has, in fact, been proposed that the clinical efficacy of these drugs largely derives from their suppressant effects on REM sleep. The three major classes of antidepressant drugs, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs), profoundly suppress REM sleep.<a href="http://www.bbsonline.org/Preprints/OldArchive/bbs.vertes.html" class="external autonumber" title="http://www.bbsonline.org/Preprints/OldArchive/bbs.vertes.html" rel="nofollow">[12]</a> The MAOIs virtually completely abolish REM sleep, while the TCAs and SSRIs have been shown to produce immediate (40-85%) and sustained (30-50%) reductions in REM sleep. Ironically, a common side effect of most antidepressants is an increase in vivid dreams, and nightmares are a common result of rapid withdrawal from MAOIs.</p>
<p><a name="Controversy" id="Controversy"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Controversy">edit</a>]</span> <span class="mw-headline">Controversy</span></h2>
<p>Several studies have stimulated doubt about the effectiveness of antidepressants. The studies cite that the difference between antidepressants and placebo is negligible (Kirsch I, Moore TJ, Scoboria A, Nicholls SS (2002a), The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention &amp; Treatment 5:Article 23<a href="http://journals.apa.org/prevention/volume5/toc-jul15-02.html" class="external autonumber" title="http://journals.apa.org/prevention/volume5/toc-jul15-02.html" rel="nofollow">[13]</a>).</p>
<p>The paper in question has been severely criticized by independent researchers, however. One reason for this is that it deals almost exclusively with the SSRI class of medication. In leveling criticism against the efficacy of SSRIs, critics state, it is not the best paper, merely the most widely known one. Also, other classes of antidepressants have demonstrated superior efficacy, and it has been argued that this paper is "throwing the baby out with the bathwater", while its thrust should in fact be levelled at the serotonin hypothesis of depression.</p>
<p>Through a <a href="../../../f/r/e/Freedom_of_Information_Act_920f.html" title="Freedom of Information Act">Freedom of Information Act</a> request, two psychologists obtained 47 studies used by the FDA for approval of the six antidepressants prescribed most widely between 1987-99. Overall, antidepressant pills worked 18% better than placebos, a statistically significant difference, "but not meaningful for people in clinical settings", says University of Connecticut psychologist Irving Kirsch. He and co-author Thomas Moore released their findings in "Prevention and Treatment", an e-journal of the American Psychological Association.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since January 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p>More than half of the 47 studies found that patients on antidepressants improved no more than those on placebos, Kirsch says. "They should have told the American public about this. The drugs have been touted as much more effective than they are." He says studies finding no benefit have been mentioned only on labeling for <a href="../../../c/e/l/Celexa.html" title="Celexa">Celexa</a>, the most recently approved drug. The others included in his evaluation: <a href="../../../p/r/o/Prozac.html" title="Prozac">Prozac</a>, <a href="../../../p/a/x/Paxil.html" title="Paxil">Paxil</a>, <a href="../../../z/o/l/Zoloft.html" title="Zoloft">Zoloft</a>, <a href="../../../e/f/f/Effexor.html" title="Effexor">Effexor</a> and <a href="../../../s/e/r/Serzone.html" title="Serzone">Serzone</a>.</p>
<p>Additional papers have been published regarding the benefits of atypical vs. typical antidepressants. These are timely papers given the need for <a href="../../../e/v/i/Evidence_based_medicine.html" title="Evidence based medicine">evidence based medicine</a>, as well as the cost of health care. Discussion of a key paper reviewing this topic titled "Quantitative analysis of sponsorship bias in economic studies of antidepressants" can be found at <a href="http://journalreview.org/view_pubmed_article.php?pmid=14645020&amp;specialty_id=18" class="external text" title="http://journalreview.org/view_pubmed_article.php?pmid=14645020&amp;specialty_id=18" rel="nofollow">an on-line journal club</a>.</p>
<p>Dr Joseph Glenmullen, a Harvard psychiatrist, has written a book on the subject for the layperson; see link below.</p>
<p><a name="Lawsuits" id="Lawsuits"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Lawsuits">edit</a>]</span> <span class="mw-headline">Lawsuits</span></h2>
<p>In many cases SSRI drug manufacturers have withheld information from the FDA and the public to play down the risks and adverse effects associated with SSRIs. This had led to litigation against many of the pharmaceutical manufacturers of SSRI anti-depressants in cases covering suicidality, SSRI withdrawal and birth defects in neonates from nursing mothers on SSRIs.</p>
<p>In one of the only three cases to ever go to trial for SSRI indication in suicide, <a href="../../../e/l/i/Eli_Lilly_1e1b.html" title="Eli Lilly">Eli Lilly</a> was caught corrupting the judicial process by making a deal with the plaintiff's attorney to throw the case, in part by not disclosing damaging evidence to the jury. The case, known as the Fentress Case involved a Kentucky man, <a href="../../../j/o/s/Joseph_Wesbecker_eaaf.html" title="Joseph Wesbecker">Joseph Wesbecker</a>, on Prozac, who went to his workplace and opened fire with an assault rifle killing 8 people (including Fentress), and injuring 12 others before turning the gun on himself. The jury returned a 9-to-3 verdict in favor of Lilly. The judge, in the end, took the matter to the Kentucky Supreme Court, which found that "there was a serious lack of candor with the trial court and there may have been deception, bad faith conduct, abuse of judicial process and, perhaps even fraud." The judge later revoked the verdict and instead, recorded the case as settled. The value of the secret settlement deal has never been disclosed, but was reportedly "tremendous".<sup id="_ref-51" class="reference"><a href="#_note-51" title="">[54]</a></sup></p>
<p>On Dec 22, 2006, a US court decided in Hoorman, et al. v. SmithKline Beecham Corp. that individuals who purchased Paxil(R) or Paxil CR(TM) (paroxetine) for a minor child may be eligible for benefits under a $63.8 million Proposed Settlement. The lawsuit won the claim that pharmaceutical maker <a href="../../../g/l/a/GlaxoSmithKline_8075.html" title="GlaxoSmithKline">GlaxoSmithKline</a> (GSK) promoted Paxil(R) or Paxil CR(TM) for prescription to children and adolescents while withholding and concealing material information about the medication's safety and effectiveness for minors.<sup id="_ref-52" class="reference"><a href="#_note-52" title="">[55]</a></sup></p>
<p>The lawsuit stemmed from a consumer advocate protest against Paroxetine manufacturer GSK. Since the FDA approved paroxetine in 1992, approximately 5,000 U.S. citizens – and thousands more worldwide – have sued GSK. Most of these people feel they were not sufficiently warned in advance of the drug's side effects and addictive properties.</p>
<p>According to the <a href="http://www.paxilprotest.com" class="external text" title="http://www.paxilprotest.com" rel="nofollow">Paxil Protest website</a>, hundreds more lawsuits have been filed against GSK.<sup id="_ref-53" class="reference"><a href="#_note-53" title="">[56]</a></sup> The Paxil Protest website was launched August 8, 2005 to offer both information about the protest and information on Paxil previously unavailable to the public. Just three weeks after its launch, the site received more than a quarter of a million hits.</p>
<p>The original Paxil Protest website is no longer available. It is understood that the action to remove the site from the internet was undertaken as part of a confidentiality agreement or 'gagging order' which the owner of the site entered into as part of a settlement of his action against GlaxoSmithKline. (However, in March 2007, the website Seroxat Secrets <a href="http://seroxatsecrets.wordpress.com/2007/03/03/the-paxil-protest-time-machine/" class="external autonumber" title="http://seroxatsecrets.wordpress.com/2007/03/03/the-paxil-protest-time-machine/" rel="nofollow">[14]</a>discovered that an archive of Paxil Protest site <a href="http://web.archive.org/web/20060519170044/http://paxilprotest.com/" class="external autonumber" title="http://web.archive.org/web/20060519170044/http://paxilprotest.com/" rel="nofollow">[15]</a>was still available on the internet via Archive.org) Gagging orders are common in such cases and can extend to documents that defendants wish to remain hidden from the public. However in some cases, such documents can become public at a later date, such as those made public by Peter Breggin in February of 2006. A press release from Dr. Breggin can be seen here: <a href="http://www.breggin.com/courtfiling.pbreggin.2006.html" class="external autonumber" title="http://www.breggin.com/courtfiling.pbreggin.2006.html" rel="nofollow">[16]</a></p>
<p>In January 2007, according to the Seroxat Secrets website, <a href="http://seroxatsecrets.wordpress.com" class="external autonumber" title="http://seroxatsecrets.wordpress.com" rel="nofollow">[17]</a>, the national group litigation in the <a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">United Kingdom</a>, on behalf of several hundred people who allege withdrawal reactions through their use of the drug Seroxat, against GlaxoSmithKline plc, moved a step closer to the High Court in <a href="../../../l/o/n/London.html" title="London">London</a>, with the confirmation that Public Funding had been reinstated following a decision by the Public Interest Appeal Panel. The issue at the heart of this particular action claims Seroxat is a defective drug in that it has a propensity to cause a withdrawal reaction. Hugh James Solicitors confirm this news on their website <a href="http://www.hughjames.com/lifestyle/groupactions/seroxt.html" class="external autonumber" title="http://www.hughjames.com/lifestyle/groupactions/seroxt.html" rel="nofollow">[18]</a></p>
<p>On January 29 2007, the BBC in the UK aired a fourth documentary in its 'Panorama' <a href="http://news.bbc.co.uk/1/hi/programmes/panorama/5346938.stm" class="external autonumber" title="http://news.bbc.co.uk/1/hi/programmes/panorama/5346938.stm" rel="nofollow">[19]</a> series about the controversial drug Seroxat. This programme, entitled Secrets of the Drug Trials, focuses on on three GSK paediatric clinical trials on depressed children and adolescents. The documentary claims Seroxat could not be proven to work for teenagers, and that one clinical trial indicated they were six times more likely to become suicidal after taking it.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p><a name="Non-mainstream_treatments" id="Non-mainstream_treatments"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Non-mainstream treatments">edit</a>]</span> <span class="mw-headline">Non-mainstream treatments</span></h2>
<p>There are numerous alternative treatments for depression, whether medications or other kinds of intervention.</p>
<p>Various <a href="../../../o/p/i/Opiates.html" title="Opiates">Opiates</a> were commonly used as antidepressants until the mid-1950s, when they fell out of favor with medical orthodoxy due to their addictive nature, the tolerance buildup issues and their side-effect profile. Today the use of opioids in treating depression is a large taboo in the medical field due to associations with drug abuse; hence, research has proceeded at a very slow rate. A small <a href="../../../c/l/i/Clinical_trial.html" title="Clinical trial">clinical trial</a> conducted at Harvard Medical School in 1995<a href="http://opioids.com/buprenorphine/buprefdep.html" class="external autonumber" title="http://opioids.com/buprenorphine/buprefdep.html" rel="nofollow">[20]</a>, demonstrated that a majority of treatment-refractory, unipolar, non-<a href="../../../p/s/y/Psychotic.html" title="Psychotic">psychotic</a>, major depression patients could be successfully treated with an opioid medication called <a href="../../../b/u/p/Buprenorphine.html" title="Buprenorphine">Buprenorphine</a>, which is a partial mu agonist and potent kappa antagonist. The exact mechanism of its action in depression is not known, as kappa antagonists are antidepressants in their own right. While opioids have been proven to substantially relieve symptoms of depression for a large class of patients, re-acceptance of this fact has been severely hampered by governmental narcotic <a href="../../../p/r/o/Prohibition_%28drugs%29.html" title="Prohibition (drugs)">prohibition</a> efforts, and the (until buprenorphine) lack of alternatives with low risk of tolerance and addiction. <a href="../../../b/u/p/Buprenorphine.html" title="Buprenorphine">Buprenorphine</a> is generally preferred as the first-line opiate in depression treatment, as managing the tolerance buildup of other opiates can be complicated.</p>
<p><a href="../../../g/a/m/Gamma-Hydroxybutyric_acid_be6f.html" title="Gamma-Hydroxybutyric acid">Gamma-Hydroxybutyric acid</a> (<a href="../../../g/h/b/GHB_10bc.html" title="GHB">GHB</a>) has been used by some as an antidepressant. <a href="../../../c/l/a/Claude_Rifat_351e.html" title="Claude Rifat">Claude Rifat</a>, a French biologist, conducted some early research into GHB's antidepressant potential. Rifat noted that GHB did not cause the emotional blunting effects caused by conventional antidepressants, but instead intensified pleasurable and rewarding feelings in the user while powerfully suppressing depression.<a href="http://www.shaman-australis.com/~claude/gamma_oh1.html" class="external autonumber" title="http://www.shaman-australis.com/~claude/gamma_oh1.html" rel="nofollow">[21]</a> However, GHB has now been outlawed, except for use as a prescription treatment for narcolepsy.</p>
<p>Clinical trials have shown the effect of <a href="../../../a/c/u/Acupuncture.html" title="Acupuncture">acupuncture</a> to be comparable with amitriptyline; in addition, acupuncture has been found to be more effective in depressive patients with decreased excretion of 3-methyl-4-hydroxy-phenylglycol (the principal metabolite of the central neurotransmitter norepinephrine), while amitriptyline is more effective for those with inhibition in the dexamethasone suppression test.<sup id="_ref-54" class="reference"><a href="#_note-54" title="">[57]</a></sup> Acupuncture has also been proven to prompt the body to produce greater levels of <a href="../../../e/n/d/Endorphins.html" title="Endorphins">endorphins</a>.<sup id="_ref-55" class="reference"><a href="#_note-55" title="">[58]</a></sup></p>
<p>Most studies conclude that St. John's wort is usually as effective against depressions as other modern medication, again with fewer side effects, and it is widely prescribed for depression in Europe. A recent study showed St. John's wort to be no more effective than a placebo in cases of severe depression, although an SSRI was also no more effective on the primary outcome measure.<sup id="_ref-56" class="reference"><a href="#_note-56" title="">[59]</a></sup></p>
<p>The amino acid derivative <a href="../../../s/-/a/S-adenosyl_methionine.html" title="S-adenosyl methionine">SAM-e</a> has been studied in recent years<sup id="_ref-57" class="reference"><a href="#_note-57" title="">[60]</a></sup><sup id="_ref-58" class="reference"><a href="#_note-58" title="">[61]</a></sup></p>
<p><a href="../../../t/r/y/Tryptophan.html" title="Tryptophan">Tryptophan</a> dietary supplements, although banned in many countries due to impurities that caused a blood disease, have also been used as natural antidepressants.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since January 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup> Dietary supplements of <a href="../../../5/-/h/5-HTP_4fde.html" title="5-HTP">5-HTP</a>, a chemical the body forms from tryptophan and uses to make serotonin, have shown some promising research results but need further study.</p>
<p>NMDA antagonists such as <a href="../../../k/e/t/Ketamine.html" title="Ketamine">ketamine</a> and <a href="../../../d/e/x/Dextromethorphan.html" title="Dextromethorphan">dextromethorphan</a> have recently gained some interest in this field as their apparent ability to reverse opioid tolerance, and can give fast-acting dramatic effects. However, their acute psychoactive effects have been a problem.<sup id="_ref-59" class="reference"><a href="#_note-59" title="">[62]</a></sup></p>
<p><a href="../../../m/e/m/Memantine.html" title="Memantine">Memantine</a>, a moderate affinity NMDA antagonist, has been used to avoid tolerance buildup, and has seen use in opioid tolerance reversal. Proglumide is used to induce acute reversal of tolerance prior to this maintenance strategy; it does not work by itself in the long term, due to tolerance to its effects.</p>
<p><a href="../../../o/p/i/Opiorphin.html" title="Opiorphin">Opiorphin</a> is a very recently discovered substance that increases the effectiveness of endorphins, meaning that it has effects similar to opioid agonists without the addiction and withdrawal effects. While it has been shown to be extremely effective for <a href="../../../a/n/a/Analgesia.html" title="Analgesia">analgesia</a>, any ability to treat depression or the presence of an abuse potential are largely informed guesswork at this stage.</p>
<p><br /></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> Vega, JA., Mortimer, AM., Tyson, PJ. (2003) <a href="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=14860127" class="external text" title="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=14860127" rel="nofollow">Conventional antipsychotic prescription in unipolar depression, I: An audit and recommendations for practice</a> <i>The Journal of clinical psychiatry</i> 64(5), pp. 568-574.</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> Petty F, Trivedi MH, Fulton M, Rush AJ. (1995) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=8573660" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=8573660" rel="nofollow">Benzodiazepines as antidepressants: does GABA play a role in depression?</a> <i>Biological Psychiatry.</i> 38(9):578-91</li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> Weber, M.M. &amp; Emrich, H.M. (1988) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3153713&amp;dopt=Abstract" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3153713&amp;dopt=Abstract" rel="nofollow">Current and historical concepts of opiate treatment in psychiatric disorders.</a> <i>International Journal of Clinical Psychopharmacology.</i> Jul;3(3):255-66.</li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> Czygan, F.C. (2003) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=12784538" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=12784538" rel="nofollow">From a 2500 year old apotropic comes a current antidepressive. The cultural history and mistique of St. John's wort</a> <i>Pharm Unserer Zeit.</i> 32(3):184-90</li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <a href="http://www.time.com/time/magazine/article/0,9171,862555,00.html" class="external text" title="http://www.time.com/time/magazine/article/0,9171,862555,00.html" rel="nofollow">Time Magazine (1957)</a> "Psychic Energizer"</li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> Kuhn, R. (1958) <a href="http://ajp.psychiatryonline.org/cgi/content/abstract/115/5/459?ijkey=366b7fc177f17d99017ed6276c3fa6a9411f8a7c&amp;keytype2=tf_ipsecsha" class="external text" title="http://ajp.psychiatryonline.org/cgi/content/abstract/115/5/459?ijkey=366b7fc177f17d99017ed6276c3fa6a9411f8a7c&amp;keytype2=tf_ipsecsha" rel="nofollow">The Treatment of Depressive States with G 22355 (Imipramine Hydrochloride).</a> <i>American Journal of Psychiatry</i>, 115:459-464, November</li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> Biel JH. (1964). Some rationales for the development of antidepressant drugs. Molecular modification in drug design. Adv Chem; 45: 114–39</li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> Pletscher, A. (1991) <a href="http://www.springerlink.com/content/p7483064744t02t3/" class="external text" title="http://www.springerlink.com/content/p7483064744t02t3/" rel="nofollow">The discovery of antidepressants: A winding path</a>. <i>Journal of Cellular and Molecular Life Sciences</i>, Volume 47(1)</li>
<li id="_note-8"><b><a href="#_ref-8" title="">^</a></b> Healy, D.M.D. (1999) <a href="http://www.jonmd.com/pt/re/jnmd/abstract.00005053-199903000-00007.htm;jsessionid=FTMTRLdgKD1X1CtT44qlxnzwLT1R0Lqsc4Qc2QB1BBflVQKQJF39!-1687176797!-949856145!8091!-1" class="external text" title="http://www.jonmd.com/pt/re/jnmd/abstract.00005053-199903000-00007.htm;jsessionid=FTMTRLdgKD1X1CtT44qlxnzwLT1R0Lqsc4Qc2QB1BBflVQKQJF39!-1687176797!-949856145!8091!-1" rel="nofollow">The Three Faces of the Antidepressants: A Critical Commentary on the Clinical-Economic Context of Diagnosis</a>. <i>Journal of Nervous &amp; Mental Disease.</i> 187(3):174-180</li>
<li id="_note-9"><b><a href="#_ref-9" title="">^</a></b> Domino, E.F. (1999) <a href="http://www.psychosomaticmedicine.org/cgi/content/full/61/5/591" class="external text" title="http://www.psychosomaticmedicine.org/cgi/content/full/61/5/591" rel="nofollow">History of Modern Psychopharmacology: A Personal View With an Emphasis on Antidepressants</a>. <i>Psychopharmacology and Psychosomatic Research</i>, Special Issue</li>
<li id="_note-10"><b><a href="#_ref-10" title="">^</a></b> Wong DT, Bymaster FP, Horng JS, Molloy BB. (1975) <a href="http://jpet.aspetjournals.org/cgi/content/abstract/193/3/804?ijkey=bf652ae2e25f2dc3991840225250764eb638de4c&amp;keytype2=tf_ipsecsha" class="external text" title="http://jpet.aspetjournals.org/cgi/content/abstract/193/3/804?ijkey=bf652ae2e25f2dc3991840225250764eb638de4c&amp;keytype2=tf_ipsecsha" rel="nofollow">A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy) N-methyl-3-phenylpropylamine</a>. <i>Journal of Pharmacology and Experimental Therapeutics</i>. 193, p 804–811</li>
<li id="_note-11"><b><a href="#_ref-11" title="">^</a></b> Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W &amp; Melchart D (1996) <a href="http://bmj.bmjjournals.com/cgi/content/full/313/7052/253?view=full&amp;pmid=8704532" class="external text" title="http://bmj.bmjjournals.com/cgi/content/full/313/7052/253?view=full&amp;pmid=8704532" rel="nofollow">St John’s wort for depression – an overview and meta-analysis of randomised clinical trials</a>. <i>British Medical Journal</i> 313, p253–258.</li>
<li id="_note-12"><b><a href="#_ref-12" title="">^</a></b> Muller, W.E. (2003) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=12543057" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=12543057" rel="nofollow">Current St John's wort research from mode of action to clinical efficacy.</a> <i>Pharmacol Res.</i> Feb;47(2):101-9</li>
<li id="_note-13"><b><a href="#_ref-13" title="">^</a></b> Nathan, P.J. (2001) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11277608&amp;dopt=Citation" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11277608&amp;dopt=Citation" rel="nofollow">J Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology.</a> <i>Psychopharmacol. 2001</i> Mar;15(1):47-54.</li>
<li id="_note-14"><b><a href="#_ref-14" title="">^</a></b> Freeman, H. (1996) <a href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6VM1-3WJNNMF-TX&amp;_coverDate=12%2F31%2F1996&amp;_alid=513741720&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_qd=1&amp;_cdi=6137&amp;_sort=d&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=72e4e5cb18384ee1f4f599ed1080eda7" class="external text" title="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6VM1-3WJNNMF-TX&amp;_coverDate=12%2F31%2F1996&amp;_alid=513741720&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_qd=1&amp;_cdi=6137&amp;_sort=d&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=72e4e5cb18384ee1f4f599ed1080eda7" rel="nofollow">Tolerability and safety of novel antidepressants</a>. <i>European Psychiatry</i>, 11(supplement 4), p206.</li>
<li id="_note-15"><b><a href="#_ref-15" title="">^</a></b> Sleath, B. &amp; Shih, YC. (2003) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=12600369" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=12600369" rel="nofollow">Sociological influences on antidepressant prescribing.</a> <i>Soc Sci Med.</i> Mar;56(6):1335-44.</li>
<li id="_note-16"><b><a href="#_ref-16" title="">^</a></b> Olie JP, Elomari F, Spadone C, Lepine JP. (2002) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=12386542" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=12386542" rel="nofollow">Antidepressant consumption in the global population in France</a> <i>Encephale.</i> Sep-Oct;28(5 Pt 1):411-7.</li>
<li id="_note-17"><b><a href="#_ref-17" title="">^</a></b> Raymond CB, Morgan SG, Caetano PA. (2007) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17215416" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17215416" rel="nofollow">Antidepressant utilization in british columbia from 1996 to 2004: increasing prevalence but not incidence.</a> <i>Psychiatr Serv.</i> 2007 Jan;58(1):79-84.</li>
<li id="_note-18"><b><a href="#_ref-18" title="">^</a></b> <cite style="font-style:normal">Meijer W, Heerdink E, Leufkens H, Herings R, Egberts A, Nolen W (2004). "Incidence and determinants of long-term use of antidepressants". <i>Eur J Clin Pharmacol</i> <b>60</b> (1): 57-61. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14985889" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14985889">PMID 14985889</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Incidence+and+determinants+of+long-term+use+of+antidepressants&amp;rft.title=Eur+J+Clin+Pharmacol&amp;rft.jtitle=Eur+J+Clin+Pharmacol&amp;rft.date=2004&amp;rft.volume=60&amp;rft.issue=1&amp;rft.au=Meijer+W%2C+Heerdink+E%2C+Leufkens+H%2C+Herings+R%2C+Egberts+A%2C+Nolen+W&amp;rft.pages=57-61">&#160;</span></li>
<li id="_note-19"><b><a href="#_ref-19" title="">^</a></b> McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J, Auland ME. (2000) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;list_uids=11149300&amp;dopt=Abstract" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;list_uids=11149300&amp;dopt=Abstract" rel="nofollow">Recent trends in the use of antidepressant drugs in Australia, 1990-1998.</a><i>Med J Aust.</i> Nov 6;173(9):458-61.</li>
<li id="_note-20"><b><a href="#_ref-20" title="">^</a></b> Mark Zimmerman, Michael Posternak, Michael Friedman, Naureen Attiullah, Scott Baymiller, Robert Boland, Stacie Berlowitz, Shahzad Rahman, Kirsten Uy, Steve Singer (2004) <a href="http://ajp.psychiatryonline.org/cgi/content/abstract/161/7/1285?etoc" class="external text" title="http://ajp.psychiatryonline.org/cgi/content/abstract/161/7/1285?etoc" rel="nofollow">Which Factors Influence Psychiatrists’ Selection of Antidepressants?</a> <i>Am J Psychiatry</i> 161:1285-1289</li>
<li id="_note-21"><b><a href="#_ref-21" title="">^</a></b> Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. (2002) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;list_uids=11853110&amp;dopt=Abstract" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;list_uids=11853110&amp;dopt=Abstract" rel="nofollow">A survey of prescribing practices in the treatment of depression.</a> <i>Prog Neuropsychopharmacol Biol Psychiatry.</i> Jan;26(1):177-87.</li>
<li id="_note-22"><b><a href="#_ref-22" title="">^</a></b> BBC News (July 2002) <a href="http://news.bbc.co.uk/2/hi/health/4704053.stm" class="external text" title="http://news.bbc.co.uk/2/hi/health/4704053.stm" rel="nofollow">Male GPs depression pills 'bias'</a></li>
<li id="_note-23"><b><a href="#_ref-23" title="">^</a></b> O'Brien SM, Scully P, Scott LV, Dinan TG. "Cytokine profiles in bipolar affective disorder: focus on acutely ill patients." J Affect Disord. 2006 Feb;90(2-3):263-7.</li>
<li id="_note-24"><b><a href="#_ref-24" title="">^</a></b> Obuchowicz E, Marcinowska A, Herman ZS. "Antidepressants and cytokines--clinical and experimental studies" Psychiatr Pol. 2005 Sep-Oct;39(5):921-36.</li>
<li id="_note-25"><b><a href="#_ref-25" title="">^</a></b> Hong CJ, Yu YW, Chen TJ, Tsai SJ."Interleukin-6 genetic polymorphism and Chinese major depression". Neuropsychobiology. 2005;52(4):202-5.</li>
<li id="_note-26"><b><a href="#_ref-26" title="">^</a></b> Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. "Abstract Cytokine dysregulation, inflammation and well-being". Neuroimmunomodulation. 2005;12(5):255-69</li>
<li id="_note-27"><b><a href="#_ref-27" title="">^</a></b> Kubera M, Maes M, Kenis G, Kim YK, Lason W. "Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6" Psychiatry Res. 2005 Apr 30;134(3):251-8.</li>
<li id="_note-28"><b><a href="#_ref-28" title="">^</a></b> Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. "Cytokine dysregulation, inflammation and well-being". Neuroimmunomodulation. 2005;12(5):255-69</li>
<li id="_note-29"><b><a href="#_ref-29" title="">^</a></b> Diamond M, Kelly JP, Connor TJ. "Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade". Eur Neuropsychopharmacol. 2006 Oct;16(7):481-90.</li>
<li id="_note-30"><b><a href="#_ref-30" title="">^</a></b> Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M. "Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio." J Clin Psychopharmacol. 2001 Apr;21(2):199-206</li>
<li id="_note-31"><b><a href="#_ref-31" title="">^</a></b> Maes M."The immunoregulatory effects of antidepressants". Hum Psychopharmacol. 2001 Jan;16(1):95-103</li>
<li id="_note-32"><b><a href="#_ref-32" title="">^</a></b> Maes M, Kenis G, Kubera M, De Baets M, Steinbusch H, Bosmans E."The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway". Int Immunopharmacol. 2005 Mar;5(3):609-18.</li>
<li id="_note-33"><b><a href="#_ref-33" title="">^</a></b> Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB. "A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice." Int Immunopharmacol. 2006 Jun;6(6):903-7</li>
<li id="_note-34"><b><a href="#_ref-34" title="">^</a></b> Kulmatycki KM, Jamali F. "Drug disease interactions: role of inflammatory mediators in depression and variability in antidepressant drug response". J Pharm Pharm Sci. 2006;9(3):292-306.</li>
<li id="_note-35"><b><a href="#_ref-35" title="">^</a></b> O'Brien SM, Scott LV, Dinan TG. "Cytokines: abnormalities in major depression and implications for pharmacological treatment". Hum Psychopharmacol. 2004 Aug;19(6):397-403.</li>
<li id="_note-36"><b><a href="#_ref-36" title="">^</a></b> Anderson IM (2000) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10760555&amp;dopt=Citation" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10760555&amp;dopt=Citation" rel="nofollow">Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability</a> <i>Journal of Affective Disorders.</i> 58(1), 19-3</li>
<li id="_note-37"><b><a href="#_ref-37" title="">^</a></b> MacGillivray, S., Arroll,B., Hatcher,S., Ogston,S., Reid,I., Sullivan, F., Williams,B., Crombie,I. (2003) <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=154760" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=154760" rel="nofollow">Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis</a> <i>BMJ.</i> May 10; 326(7397): 1014.</li>
<li id="_note-38"><b><a href="#_ref-38" title="">^</a></b> Parker G, Roy K, Wilhelm K, Mitchell P. (2001) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=11247097" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=11247097" rel="nofollow">Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study.</a> <i>J Clin Psychiatry.</i> Feb;62(2):117-25.</li>
<li id="_note-39"><b><a href="#_ref-39" title="">^</a></b> Moncrieff J, Wessely S, Hardy R. (2004) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Display&amp;DB=pubmed" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Display&amp;DB=pubmed" rel="nofollow">Active placebos versus antidepressants for depression.</a> <i>Cochrane Database Syst Rev.</i> (1):CD003012.</li>
<li id="_note-40"><b><a href="#_ref-40" title="">^</a></b> Lotufo-Neto, F., Trivedi, M., &amp; Thase, M.E. (1999) <a href="http://www.nature.com/npp/journal/v20/n3/full/1395258a.html" class="external text" title="http://www.nature.com/npp/journal/v20/n3/full/1395258a.html" rel="nofollow">Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase Type A Moclobemide and Brofaromine for the Treatment of Depression</a> <i>Neuropsychopharmacology</i> 20 226-247.10.1038</li>
<li id="_note-41"><b><a href="#_ref-41" title="">^</a></b> Linde K, Mulrow CD, Berner M, Egger M. (2005) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=15846605" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=15846605" rel="nofollow">St John's wort for depression.</a> Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448.</li>
<li id="_note-42"><b><a href="#_ref-42" title="">^</a></b> Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. (2004) <a href="http://www.bmj.com/cgi/content/full/328/7444/879?ijkey=4f893b9f91cb92fde9abb867c1dd21fb35b7b9d3&amp;keytype2=tf_ipsecsha" class="external text" title="http://www.bmj.com/cgi/content/full/328/7444/879?ijkey=4f893b9f91cb92fde9abb867c1dd21fb35b7b9d3&amp;keytype2=tf_ipsecsha" rel="nofollow">Efficacy and safety of antidepressants for children and adolescents.</a> BMJ. 2004 Apr 10;328(7444):879-83.</li>
<li id="_note-43"><b><a href="#_ref-43" title="">^</a></b> Baghai, TC., Moller, HJ, Rupprecht, R. (2006) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=16472142" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=16472142" rel="nofollow">Recent progress in pharmacological and non-pharmacological treatment options of major depression.</a> <i>Curr Pharm Des.</i>&#160;;12(4):503-15.</li>
<li id="_note-SSRIswitch">^ <a href="#_ref-SSRIswitch_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-SSRIswitch_1" title=""><sup><i><b>b</b></i></sup></a> Ruhe HG, Huyser J, Swinkels JA, Schene AH. (2006)<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17194261&amp;query_hl=25&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17194261&amp;query_hl=25&amp;itool=pubmed_docsum" rel="nofollow">Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.</a> <i>J Clin Psychiatry.</i> Dec;67(12):1836-55.</li>
<li id="_note-44"><b><a href="#_ref-44" title="">^</a></b> Tranter, R., O'Donovan, CO., Chandarana, P., Kennedy, S. (2002) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=12174733&amp;query_hl=40&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=12174733&amp;query_hl=40&amp;itool=pubmed_docsum" rel="nofollow">Prevalence and outcome of partial remission in depression</a> <i>J Psychiatry Neurosci.</i> July; 27(4): 241–247.</li>
<li id="_note-45"><b><a href="#_ref-45" title="">^</a></b> Byrne, SE. &amp; Rothschild, AJ. (1999) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9671339&amp;dopt=Abstract" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9671339&amp;dopt=Abstract" rel="nofollow">Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments.</a> <i>J Clin Psychiatry.</i> Jun;59(6):279-88.</li>
<li id="_note-46"><b><a href="#_ref-46" title="">^</a></b> Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M. (2000) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;list_uids=10900529&amp;dopt=Abstract" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;list_uids=10900529&amp;dopt=Abstract" rel="nofollow">Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.</a> <i>Can J Psychiatry.</i> Jun;45(5):476-81.</li>
<li id="_note-augment"><b><a href="#_ref-augment_0" title="">^</a></b> DeBattista C, Lembke A. (2005) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16318821&amp;query_hl=29&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16318821&amp;query_hl=29&amp;itool=pubmed_docsum" rel="nofollow">Update on augmentation of antidepressant response in resistant depression.</a> <i>Curr Psychiatry Rep.</i> Dec;7(6):435-40.</li>
<li id="_note-47"><b><a href="#_ref-47" title="">^</a></b> Lam RW, Wan DD, Cohen NL, Kennedy SH. (2002) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12197448" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12197448" rel="nofollow">Combining antidepressants for treatment-resistant depression: a review.</a> <i>J Clin Psychiatry.</i> Aug;63(8):685-93.</li>
<li id="_note-48"><b><a href="#_ref-48" title="">^</a></b> Geddes JR et al. (2003) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12606176&amp;dopt=Abstract" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12606176&amp;dopt=Abstract" rel="nofollow">Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.</a> <i>Lancet.</i> Feb 22;361(9358):653-61.</li>
<li id="_note-49"><b><a href="#_ref-49" title="">^</a></b> Fava GA, Park SK, Sonino N. (2006) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17144786&amp;query_hl=35&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17144786&amp;query_hl=35&amp;itool=pubmed_docsum" rel="nofollow">Treatment of recurrent depression.</a> <i>Expert Rev Neurother.</i> Nov;6(11):1735-40.</li>
<li id="_note-50"><b><a href="#_ref-50" title="">^</a></b> Peterson, TJ. (2006) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16644768&amp;query_hl=42&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16644768&amp;query_hl=42&amp;itool=pubmed_docsum" rel="nofollow">Enhancing the efficacy of antidepressants with psychotherapy</a> <i>Journal of Psychopharmacology</i>, Vol. 20, No. 3 suppl, 19-28, 2006</li>
<li id="_note-51"><b><a href="#_ref-51" title="">^</a></b> <a href="http://www.judicialaccountability.org/articles/hideandseek.htm" class="external autonumber" title="http://www.judicialaccountability.org/articles/hideandseek.htm" rel="nofollow">[1]</a> from Richard Zitrin &amp; Carol M. Langford. "Hide and Secrets in Louisville" from "The Moral Compass of the American Lawyer". Ballantine Books, 1999</li>
<li id="_note-52"><b><a href="#_ref-52" title="">^</a></b> <a href="http://www.ahrp.org/risks/SSRI0204/GSKpaxil/pg1.html" class="external autonumber" title="http://www.ahrp.org/risks/SSRI0204/GSKpaxil/pg1.html" rel="nofollow">[2]</a> October 1998 GSK Internal Memo: Strategy of Concealment</li>
<li id="_note-53"><b><a href="#_ref-53" title="">^</a></b> <a href="http://www.newstarget.com/011470.html" class="external autonumber" title="http://www.newstarget.com/011470.html" rel="nofollow">[3]</a> Newstarget September 06, 2005</li>
<li id="_note-54"><b><a href="#_ref-54" title="">^</a></b> World Health Organisation, Acupuncture: Review and Analysis of Reports on Controlled Clinical Trials, 2002</li>
<li id="_note-55"><b><a href="#_ref-55" title="">^</a></b> <a href="http://www.abc.net.au/science/news/stories/s27924.htm" class="external text" title="http://www.abc.net.au/science/news/stories/s27924.htm" rel="nofollow">ABC Australia Science News on acupuncuture</a></li>
<li id="_note-56"><b><a href="#_ref-56" title="">^</a></b> Hypericum Depression Trial Study Group (2002). Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder: A Randomized Controlled Clinical Trial. JAMA, 287 (14):1807-1814</li>
<li id="_note-57"><b><a href="#_ref-57" title="">^</a></b> Roberto Delle Chiaie, Paolo Pancheri and Pierluigi Scapicchio. (2002). Efficacy and tolerability of oral and intramuscular S-adenosyl- L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr, 76 (5): 1172S-1176S</li>
<li id="_note-58"><b><a href="#_ref-58" title="">^</a></b> Mischoulon D, Fava M. (2002). Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr, 76 (5): 1158S-61S.</li>
<li id="_note-59"><b><a href="#_ref-59" title="">^</a></b> "<a href="http://news.bbc.co.uk/1/hi/health/5253800.stm" class="external text" title="http://news.bbc.co.uk/1/hi/health/5253800.stm" rel="nofollow">Drug 'treats depression in hours'</a>", <i><a href="../../../b/b/c/BBC_a61d.html" title="BBC">BBC</a></i>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../a/u/g/August_7.html" title="August 7">08-07</a>. Retrieved on <a href="../../../s/e/p/September_17.html" title="September 17">September 17</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
</ol>
</div>
<p><a name="Additional_reading" id="Additional_reading"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: Additional reading">edit</a>]</span> <span class="mw-headline">Additional reading</span></h2>
<ul>
<li>David Healy, <i>The Antidepressant Era</i>, Paperback Reprint Edition, Harvard University Press (1999) <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0674039580</a></li>
</ul>
<ul>
<li>Peter D. Kramer, <i>Listening to Prozac: The Landmark Book about Anti-Depressants and the Remaking of the Self</i>, Paperback Revised Edition, Penguin (1997) <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0140266712</a></li>
</ul>
<ul>
<li>Syd Baumel, <i>Natural Antidepressants</i>, Paperback 1st edition, McGraw-Hill (1999) <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0879839007</a></li>
</ul>
<ul>
<li>Stephen M. Stahl, <i>Psychopharmacology of Antidepressants</i>, Paperback 1st Edition, Taylor &amp; Francis (1997) <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 1853175137</a></li>
</ul>
<ul>
<li>Pacher P, Kecskemeti V. <i>Trends in the development of new antidepressants. Is there a light at the end of the tunnel?</i> Curr Med Chem. 2004 Apr;11(7):925-43. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15078174" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15078174">PMID 15078174</a></li>
</ul>
<ul>
<li>Pacher P, Kohegyi E, Kecskemeti V, Furst S. <i>Current trends in the development of new antidepressants.</i>Curr Med Chem. 2001 Feb;8(2):89-100. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11172668" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11172668">PMID 11172668</a></li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antidepressant.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<div class="infobox sisterproject">
<div class="floatleft"><span><a href="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" class="image" title=""><img src="../../../upload/thumb/4/4a/Commons-logo.svg/50px-Commons-logo.svg.png" alt="" width="50" height="67" longdesc="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" /></a></span></div>
<div style="margin-left: 60px;"><a href="../../../w/i/k/Wikimedia_Commons_7b57.html" title="Wikimedia Commons">Wikimedia Commons</a> has media related to:
<div style="margin-left: 10px;"><i><b><a href="http://commons.wikimedia.org/wiki/Category:Antidepressants" class="extiw" title="commons:Category:Antidepressants">Antidepressants</a></b></i></div>
</div>
</div>
<div class="infobox sisterproject" style="float:right;">
<div style="float: left;">
<div class="floatnone"><span><a href="../../../w/i/k/Image%7EWiktionary-logo-en.png_23eb.html" class="image" title=""><img src="../../../upload/shared/thumb/b/b4/Wiktionary-logo-en.png/50px-Wiktionary-logo-en.png" alt="" width="50" height="54" longdesc="../../../w/i/k/Image%7EWiktionary-logo-en.png_23eb.html" /></a></span></div>
</div>
<div style="margin-left: 60px;">Look up <i><b><a href="http://en.wiktionary.org/wiki/antidepressant" class="extiw" title="wiktionary:antidepressant">antidepressant</a></b></i> in<br />
<a href="../../../w/i/k/Wiktionary.html" title="Wiktionary">Wiktionary</a>, the free dictionary.</div>
</div>
<ul>
<li><a href="http://www.drada.org/ReferenceShelf/goldstein.html" class="external text" title="http://www.drada.org/ReferenceShelf/goldstein.html" rel="nofollow">Pharmacological treatment of Mood Disorders</a></li>
<li><a href="http://www.nih.gov/news/pr/aug2003/nimh-07.htm" class="external text" title="http://www.nih.gov/news/pr/aug2003/nimh-07.htm" rel="nofollow">Creation of New Neurons Critical to Antidepressant Action in Mice</a></li>
<li><a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10%2E1371%2Fjournal%2Epmed%2E0030240" class="external text" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10%2E1371%2Fjournal%2Epmed%2E0030240" rel="nofollow">Do Antidepressants Cure or Create Abnormal Brain States?</a> - Article by Joanna Moncrieff and David Cohen in PLoS Medicine.</li>
<li><a href="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_final.pdf" class="external text" title="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_final.pdf" rel="nofollow">NIH Expert Panel Report on the reproductive and developmental toxicology of Prozac (Fluoxetine)</a></li>
<li><a href="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_monograph.pdf" class="external text" title="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_monograph.pdf" rel="nofollow">NIH Monograph on the potential human reproductive and developmental effects of Prozac (Fluoxetine)</a></li>
<li><a href="http://www.psych.org/psych_pract/treatg/pg/MDD.watch.pdf" class="external text" title="http://www.psych.org/psych_pract/treatg/pg/MDD.watch.pdf" rel="nofollow">American Psychiatric Association 1995 Practice Guideline for the Treatment of Patients with Major Depressive Disorder</a></li>
<li><a href="http://childadvocate.net/childpresentations/child_medication.htm" class="external text" title="http://childadvocate.net/childpresentations/child_medication.htm" rel="nofollow">Children and Medication - a multimodal presentation</a></li>
<li><a href="http://www.bap.org.uk/consensus/antidepressant.pdf" class="external text" title="http://www.bap.org.uk/consensus/antidepressant.pdf" rel="nofollow">British Association for Psychopharmacology 2000 Evidence Based Guidelines for Treating Depressive Disorders with Antidepressants</a></li>
<li><a href="http://biopsychiatry.com/index.html" class="external text" title="http://biopsychiatry.com/index.html" rel="nofollow">The Good Drug Guide: new mood-brighteners and antidepressants</a></li>
<li><a href="http://www.yoism.org/?q=node/234" class="external text" title="http://www.yoism.org/?q=node/234" rel="nofollow">Video of Loren Mosher, M.D.</a> (first Chief of Schizophrenia Studies at <a href="../../../n/i/m/NIMH_977b.html" title="NIMH">NIMH</a> and founding editor of the <i>Schizophrenia Bulletin</i>) discussing the difficulties in giving true <a href="../../../i/n/f/Informed_consent.html" title="Informed consent">informed consent</a> regarding the SSRI's and his belief that there is a link between <a href="../../../s/c/h/School_shooters.html" title="School shooters">school shooters</a>, <a href="../../../s/u/i/Suicide.html" title="Suicide">suicide</a>, and the SSRI's</li>
<li><a href="http://bmj.bmjjournals.com/cgi/content/full/330/7488/420" class="external text" title="http://bmj.bmjjournals.com/cgi/content/full/330/7488/420" rel="nofollow">Joanna Moncrieff: Evidence base for older antidepressants is shaky too. BMJ 2005;330:420 (19 February)</a></li>
<li><a href="http://www.healyprozac.com/Book/Introduction.pdf" class="external text" title="http://www.healyprozac.com/Book/Introduction.pdf" rel="nofollow">Introduction to <i>Let Them Eat Prozac</i> by David Healy</a></li>
<li><a href="http://www.rcpsych.ac.uk/mentalhealthinformation/mentalhealthproblems/depression/antidepressants.aspx" class="external text" title="http://www.rcpsych.ac.uk/mentalhealthinformation/mentalhealthproblems/depression/antidepressants.aspx" rel="nofollow">An information leaflet from the Royal College of Psychiatrists</a></li>
</ul>
<p><br /></p>
<table class="navbox collapsible" style="margin:auto; text-align=left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; width:6em; text-align:left;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../a/n/t/Template%7EAntidepressants_b6a6.html" title="Template:Antidepressants"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../a/n/t/Template_talk%7EAntidepressants_2d19.html" title="Template talk:Antidepressants"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../a/n/t/Template%7EAntidepressants_b6a6.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Template%7EAntidepressants_b6a6.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<span style="font-size:110%;"><strong class="selflink">Antidepressants</strong> (<a href="../../../a/t/c/ATC_code_N06_9c1c.html#N06A_Antidepressants" title="ATC code N06">ATC N06A</a>)</span></th>
</tr>
<tr>
<th style=""><a href="../../../m/o/n/Monoamine_oxidase_inhibitor.html" title="Monoamine oxidase inhibitor">Monoamine oxidase inhibitors</a> (MAOI)</th>
<td style="" colspan="1"><a href="../../../h/a/r/Harmaline.html" title="Harmaline">Harmaline</a>, <a href="../../../i/p/r/Iproniazid.html" title="Iproniazid">Iproniazid</a>, <a href="../../../i/s/o/Isocarboxazid.html" title="Isocarboxazid">Isocarboxazid</a>, <a href="../../../n/i/a/Nialamide.html" title="Nialamide">Nialamide</a>, <a href="../../../p/a/r/Pargyline.html" title="Pargyline">Pargyline</a>, <a href="../../../p/h/e/Phenelzine.html" title="Phenelzine">Phenelzine</a>, <a href="../../../s/e/l/Selegiline.html" title="Selegiline">Selegiline</a>, <a href="../../../t/o/l/Toloxatone.html" title="Toloxatone">Toloxatone</a>, <a href="../../../t/r/a/Tranylcypromine.html" title="Tranylcypromine">Tranylcypromine</a><br />
<i><a href="../../../r/e/v/Reversible_inhibitor_of_monoamine_oxidase_A_da48.html" title="Reversible inhibitor of monoamine oxidase A">RIMAs</a>:</i> <a href="../../../b/r/o/Brofaromine.html" title="Brofaromine">Brofaromine</a>, <a href="../../../m/o/c/Moclobemide.html" title="Moclobemide">Moclobemide</a></td>
</tr>
<tr>
<th style=""><a href="../../../d/o/p/Dopamine_reuptake_inhibitor.html" title="Dopamine reuptake inhibitor">Dopamine reuptake inhibitor</a> (DARI)</th>
<td style="" colspan="1"><a href="../../../a/m/i/Amineptine.html" title="Amineptine">Amineptine</a>, <a href="../../../p/h/e/Phenmetrazine.html" title="Phenmetrazine">Phenmetrazine</a>, <a href="../../../v/a/n/Vanoxerine.html" title="Vanoxerine">Vanoxerine</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Norepinephrine-dopamine_reuptake_inhibitor.html" title="Norepinephrine-dopamine reuptake inhibitor">Norepinephrine-dopamine reuptake inhibitors</a> (NDRI)</th>
<td style="" colspan="1"><a href="../../../b/u/p/Bupropion.html" title="Bupropion">Bupropion</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Norepinephrine_reuptake_inhibitor.html" title="Norepinephrine reuptake inhibitor">Norepinephrine reuptake inhibitor</a> (NRI) or (NARI)</th>
<td style="" colspan="1"><a href="../../../a/t/o/Atomoxetine.html" title="Atomoxetine">Atomoxetine</a>, <a href="../../../m/a/p/Maprotiline.html" title="Maprotiline">Maprotiline</a>, <a href="../../../r/e/b/Reboxetine.html" title="Reboxetine">Reboxetine</a>, <a href="../../../v/i/l/Viloxazine.html" title="Viloxazine">Viloxazine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/r/Serotonin-norepinephrine_reuptake_inhibitor.html" title="Serotonin-norepinephrine reuptake inhibitor">Serotonin-norepinephrine reuptake inhibitor</a> (SNRI)</th>
<td style="" colspan="1"><a href="../../../d/e/s/Desvenlafaxine.html" title="Desvenlafaxine">Desvenlafaxine</a>, <a href="../../../d/u/l/Duloxetine.html" title="Duloxetine">Duloxetine</a>, <a href="../../../m/i/l/Milnacipran.html" title="Milnacipran">Milnacipran</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">Nefazodone</a>, <a href="../../../v/e/n/Venlafaxine.html" title="Venlafaxine">Venlafaxine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/l/Selective_serotonin_reuptake_inhibitor.html" title="Selective serotonin reuptake inhibitor">Selective serotonin reuptake inhibitor</a> (SSRI)</th>
<td style="" colspan="1"><a href="../../../a/l/a/Alaproclate.html" title="Alaproclate">Alaproclate</a>, <a href="../../../c/i/t/Citalopram.html" title="Citalopram">Citalopram</a>, <a href="../../../e/s/c/Escitalopram.html" title="Escitalopram">Escitalopram</a>, <a href="../../../e/t/o/Etoperidone.html" title="Etoperidone">Etoperidone</a>, <a href="../../../f/l/u/Fluoxetine.html" title="Fluoxetine">Fluoxetine</a>, <a href="../../../f/l/u/Fluvoxamine.html" title="Fluvoxamine">Fluvoxamine</a>, <a href="../../../p/a/r/Paroxetine.html" title="Paroxetine">Paroxetine</a>, <a href="../../../s/e/r/Sertraline.html" title="Sertraline">Sertraline</a>, <a href="../../../z/i/m/Zimelidine.html" title="Zimelidine">Zimelidine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/l/Selective_serotonin_reuptake_enhancer.html" title="Selective serotonin reuptake enhancer">Selective serotonin reuptake enhancer</a> (SSRE)</th>
<td style="" colspan="1"><a href="../../../t/i/a/Tianeptine.html" title="Tianeptine">Tianeptine</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Noradrenergic_and_specific_serotonergic_antidepressant.html" title="Noradrenergic and specific serotonergic antidepressant">Noradrenergic and specific serotonergic antidepressant</a> (NaSSA)</th>
<td style="" colspan="1"><a href="../../../m/i/r/Mirtazapine.html" title="Mirtazapine">Mirtazapine</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/r/i/Tricyclic_antidepressant.html" title="Tricyclic antidepressant">Tricyclic antidepressants</a> (TCA)</th>
<td style="" colspan="1"><a href="../../../a/m/i/Amitriptyline.html" title="Amitriptyline">Amitriptyline</a>, <a href="../../../a/m/o/Amoxapine.html" title="Amoxapine">Amoxapine</a>, <a href="../../../b/u/t/Butriptyline.html" title="Butriptyline">Butriptyline</a>, <a href="../../../c/l/o/Clomipramine.html" title="Clomipramine">Clomipramine</a>, <a href="../../../d/e/s/Desipramine.html" title="Desipramine">Desipramine</a>, <a href="../../../d/i/b/Dibenzepin.html" title="Dibenzepin">Dibenzepin</a>, <a href="../../../d/o/s/Dosulepin_hydrochloride.html" title="Dosulepin hydrochloride">Dothiepin</a>, <a href="../../../d/o/x/Doxepin.html" title="Doxepin">Doxepin</a>, <a href="../../../i/m/i/Imipramine.html" title="Imipramine">Imipramine</a>, <a href="../../../i/p/r/Iprindole.html" title="Iprindole">Iprindole</a>, <a href="../../../l/o/f/Lofepramine.html" title="Lofepramine">Lofepramine</a>, <a href="../../../m/e/l/Melitracen.html" title="Melitracen">Melitracen</a>, <a href="../../../n/o/r/Nortriptyline.html" title="Nortriptyline">Nortriptyline</a>, <a href="../../../o/p/i/Opipramol.html" title="Opipramol">Opipramol</a>, <a href="../../../p/r/o/Protriptyline.html" title="Protriptyline">Protriptyline</a>, <a href="../../../t/r/i/Trimipramine.html" title="Trimipramine">Trimipramine</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/e/t/Tetracyclic_antidepressant.html" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a></th>
<td style="" colspan="1"><a href="../../../m/a/p/Maprotiline.html" title="Maprotiline">Maprotiline</a>, <a href="../../../m/i/a/Mianserin.html" title="Mianserin">Mianserin</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">Nefazodone</a>, <a href="../../../t/r/a/Trazodone.html" title="Trazodone">Trazodone</a></td>
</tr>
</table>
<table class="navbox collapsible autocollapse" style="margin:auto; text-align:left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; width:6em; text-align:left;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" title="Template:Major Drug Groups"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../m/a/j/Template_talk%7EMajor_Drug_Groups_149b.html" title="Template talk:Major Drug Groups"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" class="external text" title="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<span style="font-size:110%;">Major Drug Groups</span></th>
</tr>
<tr>
<th style=""><a href="../../../b/r/a/Brain.html" title="Brain">Brain</a> and <a href="../../../n/e/r/Nervous_system.html" title="Nervous system">Nervous system</a></th>
<td style="" colspan="1"><a href="../../../a/n/a/Analgesic.html" title="Analgesic">Analgesics</a>, <a href="../../../a/n/e/Anesthesia.html" title="Anesthesia">Anesthetics</a>, <a href="../../../a/n/x/Anxiolytic.html" title="Anxiolytic">Anxiolytics</a>, <strong class="selflink">Antidepressants</strong>, <a href="../../../a/n/t/Antipsychotic.html" title="Antipsychotic">Antipsychotics</a>, <a href="../../../a/n/t/Anticonvulsant.html" title="Anticonvulsant">Anticonvulsants</a>, <a href="../../../s/t/i/Stimulant.html" title="Stimulant">Nervous system stimulants</a>, <a href="../../../a/n/t/Antiemetic.html" title="Antiemetic">Antiemetics</a>, <a href="../../../p/s/y/Psychedelics%2C_dissociatives_and_deliriants.html" title="Psychedelics, dissociatives and deliriants">Hallucinogens</a>, <a href="../../../m/o/o/Mood_stabilizer.html" title="Mood stabilizer">Mood stabilizers</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/s/Respiratory_system.html" title="Respiratory system">Respiratory system</a></th>
<td style="" colspan="1"><a href="../../../b/r/o/Bronchodilator.html" title="Bronchodilator">Bronchodilators</a>, <a href="../../../d/e/c/Decongestant.html" title="Decongestant">Decongestants</a></td>
</tr>
<tr>
<th style=""><a href="../../../h/e/a/Heart.html" title="Heart">Heart</a> and <a href="../../../c/i/r/Circulatory_system.html" title="Circulatory system">Circulation</a></th>
<td style="" colspan="1"><a href="../../../a/c/e/ACE_inhibitor_fd43.html" title="ACE inhibitor">Angiotensin converting enzyme inhibitors</a>, <a href="../../../a/n/t/Antiarrhythmic_agent.html" title="Antiarrhythmic agent">Antiarrhythmics</a>, <a href="../../../a/n/t/Antianginal.html" title="Antianginal">Antianginals</a>, <a href="../../../a/n/t/Antihypertensive.html" title="Antihypertensive">Antihypertensives</a>, <a href="../../../h/y/p/Hypolipidemic_agent.html" title="Hypolipidemic agent">Antihyperlipidemics</a>, <a href="../../../a/n/t/Anticoagulant.html" title="Anticoagulant">Anticoagulants</a>, <a href="../../../a/n/t/Antiplatelet_drug.html" title="Antiplatelet drug">Antiplatelets</a>, <a href="../../../b/e/t/Beta_blocker.html" title="Beta blocker">Beta blockers</a>, <a href="../../../d/i/u/Diuretic.html" title="Diuretic">Diuretics</a>, <a href="../../../t/h/r/Thrombolytic_drug.html" title="Thrombolytic drug">Thrombolytics</a>, <a href="../../../v/a/s/Vasodilator.html" title="Vasodilator">Vasodilators</a></td>
</tr>
<tr>
<th style=""><a href="../../../g/a/s/Gastrointestinal_tract.html" title="Gastrointestinal tract">Gastrointestinal tract</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antacid.html" title="Antacid">Antacids</a>, <a href="../../../a/n/t/Antidiarrhoeal.html" title="Antidiarrhoeal">Antidiarrhoeals</a>, <a href="../../../h/2/-/H2-receptor_antagonist.html" title="H2-receptor antagonist">H2-receptor antagonists</a>, <a href="../../../p/r/o/Proton_pump_inhibitor.html" title="Proton pump inhibitor">Proton pump inhibitors</a>, <a href="../../../l/a/x/Laxative.html" title="Laxative">Laxatives</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/u/s/Muscle.html" title="Muscle">Muscles</a>, <a href="../../../b/o/n/Bone.html" title="Bone">Bones</a>, and <a href="../../../j/o/i/Joint.html" title="Joint">Joints</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Anti-inflammatory.html" title="Anti-inflammatory">Anti-inflammatories</a>, <a href="../../../d/i/s/Disease-modifying_antirheumatic_drug.html" title="Disease-modifying antirheumatic drug">Antirheumatics</a>, <a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../m/u/s/Muscle_relaxant.html" title="Muscle relaxant">Muscle relaxants</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/l/l/Allergy.html" title="Allergy">Allergy</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antihistamine.html" title="Antihistamine">Antihistamines</a></td>
</tr>
<tr>
<th style=""><a href="../../../i/n/f/Infection.html" title="Infection">Infections</a> and <a href="../../../i/n/f/Infestation.html" title="Infestation">Infestations</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antibiotic.html" title="Antibiotic">Antibiotics</a>, <a href="../../../a/n/t/Antiviral_drug.html" title="Antiviral drug">Antivirals</a>, <a href="../../../v/a/c/Vaccine.html" title="Vaccine">Vaccines</a>, <a href="../../../a/n/t/Antiprotozoal_agent.html" title="Antiprotozoal agent">Antiprotozoals</a>, <a href="../../../a/n/t/Antifungal_drug.html" title="Antifungal drug">Antifungals</a>, <a href="../../../a/n/t/Anthelmintic.html" title="Anthelmintic">Anthelmintics</a></td>
</tr>
<tr>
<th style=""><a href="../../../e/n/d/Endocrine_system.html" title="Endocrine system">Endocrine system</a></th>
<td style="" colspan="1"><a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../a/n/t/Anti-diabetic_drug.html" title="Anti-diabetic drug">Anti-diabetics</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/a/l/Malignant.html" title="Malignant">Malignant</a> and <a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune</a> disease</th>
<td style="" colspan="1"><a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">Anticancer agents</a>, <a href="../../../i/m/m/Immunosuppressive_drug.html" title="Immunosuppressive drug">Immunosuppressants</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/p/Reproductive_system.html" title="Reproductive system">Reproductive system</a></th>
<td style="" colspan="1"><a href="../../../h/o/r/Hormonal_contraception.html" title="Hormonal contraception">Hormonal contraception</a>, <a href="../../../f/e/r/Fertility_medication.html" title="Fertility medication">Fertility agents</a>, <a href="../../../s/e/l/Selective_estrogen_receptor_modulator.html" title="Selective estrogen receptor modulator">Selective estrogen receptor modulators</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/k/i/Skin.html" title="Skin">Skin</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antipruritic.html" title="Antipruritic">Antipruritics</a></td>
</tr>
</table>

<!-- 
Pre-expand include size: 55405 bytes
Post-expand include size: 37047 bytes
Template argument size: 17575 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/t/Antidepressant.html">http://en.wikipedia.org../../../a/n/t/Antidepressant.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_to_be_expanded_since_January_2007_bea1.html" title="Category:Articles to be expanded since January 2007">Articles to be expanded since January 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_to_be_expanded_930f.html" title="Category:All articles to be expanded">All articles to be expanded</a></span> | <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_January_2007_d984.html" title="Category:Articles with unsourced statements since January 2007">Articles with unsourced statements since January 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_February_2007_f7dc.html" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="../../../a/n/t/Category%7EAntidepressants_af63.html" title="Category:Antidepressants">Antidepressants</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/n/t/Antidepressant.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/n/t/Talk%7EAntidepressant_3281.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Antidepressant">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../af/a/n/t/Antidepressant.html">Afrikaans</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/a/n/t/Antidepressivum.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/a/n/t/Antidepresivo.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/a/n/t/Antid%C3%A9presseur.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../hr/a/n/t/Antidepresivi.html">Hrvatski</a>
	      </li>
	      	      <li>
	      <a href="../../../../ku/a/n/t/Ant%C3%AEdepresan.html">Kurdî / كوردي</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/n/t/Antidepressivum.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E6%8A%97/%E3%81%86/%E3%81%A4/%E6%8A%97%E3%81%86%E3%81%A4%E8%96%AC.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/a/n/t/Antidepressivum.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/l/e/k/Leki_przeciwdepresyjne.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/a/n/t/Antidepressivo.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D0%B4%D0%B5%D0%BF%D1%80%D0%B5%D1%81%D1%81%D0%B0%D0%BD%D1%82%D1%8B.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/m/a/s/Masennusl%C3%A4%C3%A4ke.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/n/t/Antidepressiva_l%C3%A4kemedel.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../uk/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D0%B4%D0%B5%D0%BF%D1%80%D0%B5%D1%81%D0%B0%D0%BD%D1%82.html">Українська</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 19:22, 9 April 2007 by Wikipedia user <a href="../../../t/r/u/User%7ETrubye_d2f5.html" title="User:Trubye">Trubye</a>. Based on work by Wikipedia user(s) Sedator, <a href="../../../p/w/j/User%7EPwjb_b512.html" title="User:Pwjb">Pwjb</a>, Rybolt15, <a href="../../../w/_/g/User%7EW_guice_dd47.html" title="User:W guice">W guice</a>, <a href="../../../r/j/w/User%7ERjwilmsi_027f.html" title="User:Rjwilmsi">Rjwilmsi</a>, <a href="../../../e/d/g/User%7EEdgar181_7e9b.html" title="User:Edgar181">Edgar181</a>, <a href="../../../c/m/i/User%7ECmichael_2765.html" title="User:Cmichael">Cmichael</a>, Almazi, <a href="../../../b/r/e/User%7EBreathe_ba85.html" title="User:Breathe">Breathe</a>, Roger Arch, <a href="../../../b/e/e/User%7EBeetstra_df14.html" title="User:Beetstra">Beetstra</a>, <a href="../../../s/h/e/User%7EShelfSkewed_60bf.html" title="User:ShelfSkewed">ShelfSkewed</a>, <a href="../../../e/v/e/User%7EEverSince_633b.html" title="User:EverSince">EverSince</a>, <a href="../../../g/r/c/User%7EGrcampbell_a0e7.html" title="User:Grcampbell">Grcampbell</a>, <a href="../../../d/e/l/User%7EDeli_nk_ed07.html" title="User:Deli nk">Deli nk</a>, <a href="../../../k/a/z/User%7EKazakhPol_c9da.html" title="User:KazakhPol">KazakhPol</a>, <a href="../../../m/a/j/User%7EMajorly_3081.html" title="User:Majorly">Majorly</a>, <a href="../../../s/h/a/User%7EShadowbot_64a7.html" title="User:Shadowbot">Shadowbot</a>, <a href="../../../k/a/u/User%7EKauczuk_d7b5.html" title="User:Kauczuk">Kauczuk</a>, Mweller, Doroven, <a href="../../../s/c/i/User%7EScipius_3475.html" title="User:Scipius">Scipius</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../b/e/n/User%7EBenjaminevans82_7c6f.html" title="User:Benjaminevans82">Benjaminevans82</a>, <a href="../../../b/l/a/User%7EBlack_Falcon_a2d9.html" title="User:Black Falcon">Black Falcon</a>, <a href="../../../m/a/y/User%7EMayaSimFan_fe5a.html" title="User:MayaSimFan">MayaSimFan</a>, Rearden Metal, <a href="../../../a/r/m/User%7EArmadilloFromHell_83a4.html" title="User:ArmadilloFromHell">ArmadilloFromHell</a>, Womenshealth, <a href="../../../f/l/u/User%7EFluoborate_f829.html" title="User:Fluoborate">Fluoborate</a>, <a href="../../../v/e/i/User%7EVeinor_0082.html" title="User:Veinor">Veinor</a>, Agjchs, <a href="../../../c/o/l/User%7EColonies_Chris_c27e.html" title="User:Colonies Chris">Colonies Chris</a>, <a href="../../../s/e/a/User%7ESeanMack_83e5.html" title="User:SeanMack">SeanMack</a>, <a href="../../../g/a/l/User%7EGalaxiaad_9067.html" title="User:Galaxiaad">Galaxiaad</a>, <a href="../../../m/u/s/User%7EMusicked_e8fb.html" title="User:Musicked">Musicked</a>, <a href="../../../a/h/o/User%7EAhoerstemeier_88c8.html" title="User:Ahoerstemeier">Ahoerstemeier</a>, MrBronson, Enersha, <a href="../../../d/i/n/User%7EDina_fad9.html" title="User:Dina">Dina</a>, AllysunC, PianoSpleen, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, <a href="../../../p/s/i/User%7EPsiphiorg_3dff.html" title="User:Psiphiorg">Psiphiorg</a>, <a href="../../../s/t/4/User%7EST47_d0a2.html" title="User:ST47">ST47</a>, <a href="../../../z/u/i/User%7EZuiram_fd95.html" title="User:Zuiram">Zuiram</a>, <a href="../../../f/i/r/User%7EFirefoxman_0fe6.html" title="User:Firefoxman">Firefoxman</a>, <a href="../../../c/b/h/User%7ECbh_2fae.html" title="User:Cbh">Cbh</a>, Ferhengvan, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, Jcrock, <a href="../../../a/s/t/User%7EAsterion_ed2e.html" title="User:Asterion">Asterion</a>, <a href="../../../g/o/l/User%7EGoldom_560d.html" title="User:Goldom">Goldom</a>, <a href="../../../a/r/i/User%7EAriasne_af0b.html" title="User:Ariasne">Ariasne</a>, <a href="../../../l/i/n/User%7ELinberry_9aa6.html" title="User:Linberry">Linberry</a>, Vitalis, <a href="../../../g/r/a/User%7EGraham87_fa35.html" title="User:Graham87">Graham87</a>, <a href="../../../l/i/g/User%7ELigulem_20b6.html" title="User:Ligulem">Ligulem</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../a/d/e/User%7EAdelaMae_b57f.html" title="User:AdelaMae">AdelaMae</a>, <a href="../../../o/b/l/User%7EOblivious_6899.html" title="User:Oblivious">Oblivious</a>, <a href="../../../z/z/u/User%7EZzuuzz_ab5e.html" title="User:Zzuuzz">Zzuuzz</a>, <a href="../../../t/j/d/User%7ETJDay_8173.html" title="User:TJDay">TJDay</a>, <a href="../../../a/c/h/User%7EAchmelvic_e606.html" title="User:Achmelvic">Achmelvic</a>, Suboptimal Username, <a href="../../../l/a/n/User%7ELantoka_28a7.html" title="User:Lantoka">Lantoka</a>, <a href="../../../g/i/n/User%7EGinaDana_c1d8.html" title="User:GinaDana">GinaDana</a>, <a href="../../../j/i/m/User%7EJimR_3f8c.html" title="User:JimR">JimR</a>, <a href="../../../l/i/f/User%7ELifeartist_ac03.html" title="User:Lifeartist">Lifeartist</a>, <a href="../../../f/u/h/User%7EFuhghettaboutit_b1ab.html" title="User:Fuhghettaboutit">Fuhghettaboutit</a>, <a href="../../../a/l/h/User%7EAlhutch_2589.html" title="User:Alhutch">Alhutch</a>, <a href="../../../s/h/a/User%7EShanel_222a.html" title="User:Shanel">Shanel</a>, <a href="../../../j/o/s/User%7EJossi_3859.html" title="User:Jossi">Jossi</a>, <a href="../../../v/i/n/User%7EVincej_4d69.html" title="User:Vincej">Vincej</a>, <a href="../../../r/m/k/User%7ERmky87_07f5.html" title="User:Rmky87">Rmky87</a>, <a href="../../../d/e/l/User%7EDelldot_cc92.html" title="User:Delldot">Delldot</a>, <a href="../../../k/e/l/User%7EKelly_Martin_056a.html" title="User:Kelly Martin">Kelly Martin</a>, <a href="../../../v/o/i/User%7EVoice_of_All_a6ef.html" title="User:Voice of All">Voice of All</a>, <a href="../../../b/o/b/User%7EBobblewik_fbc0.html" title="User:Bobblewik">Bobblewik</a>, <a href="../../../n/e/t/User%7ENetBot_052d.html" title="User:NetBot">NetBot</a>, <a href="../../../v/e/g/User%7EVegaDark_fa76.html" title="User:VegaDark">VegaDark</a>, <a href="../../../n/i/c/User%7ENick_Dillinger_2c06.html" title="User:Nick Dillinger">Nick Dillinger</a>, <a href="../../../d/e/a/User%7EDeathawk_f102.html" title="User:Deathawk">Deathawk</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../z/o/z/User%7EZozza_25e7.html" title="User:Zozza">Zozza</a>, <a href="../../../k/u/n/User%7EKungfuadam_b5d5.html" title="User:Kungfuadam">Kungfuadam</a>, <a href="../../../c/a/c/User%7ECacycle_6f2f.html" title="User:Cacycle">Cacycle</a>, <a href="../../../e/d/_/User%7EEd_Poor_ed4e.html" title="User:Ed Poor">Ed Poor</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, <a href="../../../m/p/n/User%7EMpnolan_66b9.html" title="User:Mpnolan">Mpnolan</a>, <a href="../../../e/e/q/User%7EEequor_b13d.html" title="User:Eequor">Eequor</a>, <a href="../../../a/n/d/User%7EAndreac_7f99.html" title="User:Andreac">Andreac</a>, <a href="../../../r/e/i/User%7EReinyday_5c19.html" title="User:Reinyday">Reinyday</a>, <a href="../../../s/l/i/User%7ESlipstream%40npj_b716.html" title="User:Slipstream@npj">Slipstream@npj</a>, <a href="../../../g/h/a/User%7EGhakko_8927.html" title="User:Ghakko">Ghakko</a>, <a href="../../../v/a/r/User%7EVarnav_fe9f.html" title="User:Varnav">Varnav</a>, <a href="../../../s/a/l/User%7ESalvadorjo_220f.html" title="User:Salvadorjo">Salvadorjo</a>, <a href="../../../f/a/b/User%7EFabiform_a7bf.html" title="User:Fabiform">Fabiform</a>, <a href="../../../n/u/n/User%7ENuno_Tavares_6b5f.html" title="User:Nuno Tavares">Nuno Tavares</a>, <a href="../../../k/n/i/User%7EKnigel_1996.html" title="User:Knigel">Knigel</a>, <a href="../../../n/i/k/User%7ENikai_7c15.html" title="User:Nikai">Nikai</a>, <a href="../../../s/a/m/User%7ESam_Hocevar_dccf.html" title="User:Sam Hocevar">Sam Hocevar</a>, Meg365@aol.com, <a href="../../../g/-/m/User%7EG-Man_797a.html" title="User:G-Man">G-Man</a>, <a href="../../../r/o/b/User%7ERobbot_3bd9.html" title="User:Robbot">Robbot</a>, <a href="../../../a/r/m/User%7EArm_8860.html" title="User:Arm">Arm</a>, <a href="../../../l/a/k/User%7ELakefall_b075.html" title="User:Lakefall">Lakefall</a>, <a href="../../../y/u/t/User%7EYuTanaka_8ed0.html" title="User:YuTanaka">YuTanaka</a>, <a href="../../../g/u/a/User%7EGuanabot_b902.html" title="User:Guanabot">Guanabot</a>, <a href="../../../m/a/n/User%7EMandel_be9b.html" title="User:Mandel">Mandel</a>, <a href="../../../k/i/m/User%7EKimiko_090c.html" title="User:Kimiko">Kimiko</a>, <a href="../../../d/e/f/User%7EDefenestration_a34b.html" title="User:Defenestration">Defenestration</a>, <a href="../../../k/a/r/User%7EKarada_595b.html" title="User:Karada">Karada</a>, <a href="../../../k/a/r/User%7EKarn_1b90.html" title="User:Karn">Karn</a>, <a href="../../../h/2/o/User%7EH2O_a495.html" title="User:H2O">H2O</a>, <a href="../../../f/u/e/User%7EFuelbottle_c429.html" title="User:Fuelbottle">Fuelbottle</a>, <a href="../../../d/e/l/User%7EDelirium_b0dc.html" title="User:Delirium">Delirium</a>, <a href="../../../w/i/k/User%7EWikibot_9002.html" title="User:Wikibot">Wikibot</a>, <a href="../../../v/a/u/User%7EVaughan_120e.html" title="User:Vaughan">Vaughan</a>, <a href="../../../t/h/e/User%7EThe_Anome_61a9.html" title="User:The Anome">The Anome</a>, <a href="../../../m/a/h/User%7EMahaabaala_a94a.html" title="User:Mahaabaala">Mahaabaala</a>, <a href="../../../r/t/c/User%7ERTC_4798.html" title="User:RTC">RTC</a>, <a href="../../../a/l/e/User%7EAlex.tan_6c56.html" title="User:Alex.tan">Alex.tan</a>, <a href="../../../e/v/e/User%7EEvercat_8d16.html" title="User:Evercat">Evercat</a>, <a href="../../../t/a/r/User%7ETarka_e0c0.html" title="User:Tarka">Tarka</a>, <a href="../../../b/i/g/User%7EBigFatBuddha_cb4d.html" title="User:BigFatBuddha">BigFatBuddha</a>, <a href="../../../r/o/a/User%7ERoadrunner_b57c.html" title="User:Roadrunner">Roadrunner</a>, <a href="../../../k/w/e/User%7EKwertii_f6e2.html" title="User:Kwertii">Kwertii</a>, <a href="../../../w/a/p/User%7EWapcaplet_7f49.html" title="User:Wapcaplet">Wapcaplet</a>, <a href="../../../s/t/e/User%7EStec_7656.html" title="User:Stec">Stec</a>, <a href="../../../a/x/e/User%7EAxelBoldt_4306.html" title="User:AxelBoldt">AxelBoldt</a>, <a href="../../../r/g/a/User%7ERgamble_65c4.html" title="User:Rgamble">Rgamble</a>, <a href="../../../r/o/s/User%7ERoseParks_d19f.html" title="User:RoseParks">RoseParks</a> and <a href="../../../m/a/r/User%7EMarXidad_95b2.html" title="User:MarXidad">MarXidad</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
